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The earliest industrial exploitation of yeast micro-organisms dates back 
thousands of years ago when the fermentation capability of Saccharomyces cerevisiae 
was harnessed for baking bread and producing alcoholic beverages. With 
advancements in cellular engineering technology, genetically engineered yeasts have 
become important microbial cell factories for producing a wide range of biochemicals 
in the biotechnological industry. Among them, the methylotrophic yeast Pichia 
pastoris has been recognized as a popular host organism for expressing protein 
molecules due to factors such as (1) its ability to achieve high cell density under 
respiratory growth, (2) its capability of performing eukaryotic post-translational 
modifications, (3) simplicity of applying genetic manipulation techniques to the 
organism and (4) low levels of endogeneous protein secretion leading to easier 
heterologous protein product purification procedures. While many experimental 
studies on recombinant protein expression in P. pastoris have been performed, a 
rational framework for engineering the methylotrophic yeast still eludes researchers. 
Towards this end, this thesis aims to develop analysis tools that can characterize the 
cellular physiology of P. pastoris to facilitate the rational design of strain 
improvement strategies for enhancing the microbe’s performance. 
A genome-scale metabolic model was reconstructed to characterize the 
metabolic capabilities of P. pastoris. The analysis of cellular metabolism using the 
constraints-based flux analysis approach enables the rational identification of 
metabolic engineering targets for strain improvement. A novel computational 
framework, known as “flux-sum analysis”, was developed to analyze the metabolite 
turnover rates during cell growth and recombinant protein production. The flux-sum 
vii 
 
analysis was able to identify essential metabolites in P. pastoris, and further 
elucidated the organism’s potential as a whole-cell biocatalyst for reducing ketone 
substrates into valuable chiral alcohols which are important precursors for producing 
fine chemicals and active pharmaceutical ingredients. 
Apart from the analysis of cellular metabolism, this thesis also examines 
potential issues in heterologous protein synthesis during the translation of mRNA to 
protein. The typically low expression of heterologous proteins has been largely 
attributed to discrepancies in codon usage patterns between the host’s native genes 
and the foreign gene. Therefore, the design of synthetic genes to enhance codon usage 
patterns was studied in detail. Computational procedures for optimizing individual 
codon usage (ICU) and codon pair usage, also known as codon context (CC), were 
developed. Surprisingly, the comparison of results from different codon optimization 
approaches revealed that CC is a relatively more important design parameter than the 
commonly considered ICU. Hence, the incorporation of CC optimization into existing 
synthetic gene design tools, which were mainly based on ICU optimization, is 
expected to produce sequences with improved protein expression capabilities. 
The in silico tools developed in this thesis are capable of incorporating high-
throughput genomic, transcriptomic and metabolomic data for the analysis and 
optimization of P. pastoris from a systems perspective. With the increasing amount of 
biological data being generated with time, the presented systems biotechnology 
framework will become an important tool for harnessing these large-scale data to 
systematically study and engineer living organisms for industrial applications. 
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Chapter 1. Introduction 
 
1.1. Background of yeasts 
The word “yeast” is derived from the Indo-European “jes-” which means boiling or 
foaming (Harper, 2012), alluding to its intrinsic ability to ferment carbohydrates 
producing alcohol and carbon dioxide observed as foaming on the culture broth. 
Indeed, yeasts are one of the oldest microorganisms being exploited by humankind for 
industrial production of fermented products. Earliest records of yeast biotechnology 
date back to about 4000 B.C. during the Neolithic Age when the species of 
Saccharomyces cerevisiae had been widely used to produce fermented alcoholic 
beverages (Cavalieri et al, 2003). Through thousands of years of technological 
advancement, the role of yeasts has greatly expanded ranging from the model 
eukaryotic organism in fundamental biological research to the cell factory for 
industrial production of value-added biochemicals. Among the various biochemicals, 
protein-based drug molecules produced by biopharmaceutical companies were 
considered the most lucrative products in the market. The sales of protein drugs, such 
as Enbrel, Remicade and Avastin, accounts for almost 20% of the global 
biopharmaceutical market with a value of close to US$ 100 billion (Walsh, 2010). 
Therefore, cellular organisms that can be genetically engineered to express these 
recombinant proteins become valuable assets to the industry. 
 




1.2. The Pichia pastoris expression system 
Over 70% of the therapeutic proteins produced in the biopharmaceutical industry are 
glycosylated. The structures of glycans attached to the protein drugs are usually 
similar to the human’s native glycosylation patterns such that the drugs are capable of 
mediating the appropriate biological functions in the patient (Hossler et al, 2009). 
Consequently, mammalian systems such as Chinese hamster ovary (CHO) cells have 
been extensively used as the industrial expression host since they are competent in 
performing complex human-like glycosylation. However, mammalian cells typically 
exhibit low survivability, low recombinant protein productivity and require expensive 
culture media, unless sophisticated experimental techniques are employed (Durocher 
& Butler, 2009). Therefore, there is a compelling need for more efficient methods of 
industrial glycoprotein production. Incidentally, recent works in the genetic 
engineering of Pichia pastoris yeast system has successfully created glycoengineered 
strains which can produce proteins with fully humanized N-linked glycosylation 
(Hamilton & Gerngross, 2007). This led to increased interest in using P. pastoris as 
the expression system for producing therapeutics, even in commercial 
biopharmaceutical companies (Gerngross, 2004). 
Although protocols for genetic engineering and in vivo culture of P. pastoris 
have been well established, the cellular metabolism of the methylotrophic yeast 
remains largely uncharacterized. The recent sequencing of P. pastoris genome has 
provided a crucial source of information for understanding the various biological 
functions in the organism (De Schutter et al, 2009). Therefore, this thesis attempts to 
harness the available biological data in the analysis of P. pastoris physiology for 
biotechnological applications. 
 




1.3. Scope of thesis 
To better understand the cellular physiology of P. pastoris, this thesis aims to develop 
an in silico model to characterize the yeast’s metabolic behavior. The metabolic 
model will be reconstructed from the organism’s genome to comprehensively capture 
all possible metabolic capabilities of the methylotrophic yeast. The reconstructed 
genome-scale metabolic model (GSMM) will be validated against experimental 
observations using a steady-state metabolic model analysis method known as the 
constraints-based flux analysis. A novel analysis method built upon the constraints-
based framework will also be presented to examine the metabolite turnover rates in P. 
pastoris. These in silico methods will be used to characterize the metabolic states 
during recombinant protein production and explore other potential biotechnological 
applications of the yeast. 
While the analysis of cellular metabolism can tackle issues in resource 
allocation to generate precursors for protein production, a major bottleneck in protein 
synthesis can still be present at the step of mRNA translation where individual amino 
acids are polymerized into the protein macromolecule according to the mRNA 
sequence. Hence, a computational framework is developed to optimize the coding 
sequence design for efficient protein synthesis. In this part of the thesis, novel 
computational procedures are applied to generate favorable coding sequence patterns, 
a process generally known as codon optimization. To ascertain the applicability of the 
developed algorithms, both in silico and in vivo validation will be carried out to 
evaluate the performance of the optimization methods. 
Through the combination of GSMM analysis and codon optimization, this 
thesis endeavors to build a comprehensive yeast systems biotechnology framework to 




aid the rational engineering of an efficient P. pastoris expression host, addressing the 




Figure 1.1. Key issues in engineering recombinant P. pastoris. 
 
 
1.4. Organization of thesis 
The remainder of this thesis is organized as follows: 
Chapter 2 provides an overview of developments in yeast systems 
biotechnology. The application of systems biology to biotechnological studies is 
discussed with particular emphasis on the importance of in silico modeling for cellular 
metabolism characterization. In order to provide a detailed representation of in vivo 
metabolic behavior, the model has to account for all possible metabolic functions 




encoded in the organism’s genome. Hence, the process of genome-scale metabolic 
model reconstruction and validation is described. 
Chapter 3 describes the reconstruction of the genome-scale metabolic model 
of P. pastoris. The steps involved in building the model based on the organism’s 
genome and metabolic pathway information found in online databases are discussed 
in detail. The uniqueness of the model is evaluated by comparing it with existing 
metabolic models of Escherichia coli and Saccharomyces cerevisiae. The model is 
then validated with experimental data to show its adequacy in representing cellular 
metabolism of P. pastoris. It is noted that the content of this chapter has been 
published in the online journal of Microbial Cell Factories (Chung et al, 2010). 
Chapter 4 presents a novel development in constraints-based flux analysis that 
can be used to quantify metabolite turnover rates under the steady-state condition. 
This new method of analysis, called flux-sum analysis, aims at providing a 
metabolite-centric perspective to identify the roles of metabolites in cellular 
metabolism. Besides classifying metabolites based on their turnover rates, flux-sum 
analysis can also elucidate the topological organization of the metabolites within the 
network. Finally, the application of flux-sum analysis to biotechnology is 
demonstrated in the study of succinate production in E. coli. It is noted that the 
content of this chapter has been published in the online journal of BMC Systems 
Biology (Chung & Lee, 2009). 
Chapter 5 demonstrates the application of the P. pastoris GSMM developed in 
Chapter 3 to analyze its cellular metabolism during recombinant protein production. 
The flux-sum analysis method delineated in Chapter 4 was used to elucidate the 
metabolite turnover rates for different carbon source utilization conditions. Results 
from flux-sum analysis were further examined to explore the potential use of P. 




pastoris as a biocatalyst for the conversion of ketones to value-added chiral alcohols. 
It is noted that some parts of this chapter has been published in the online journal of 
Microbial Cell Factories (Chung et al, 2010). 
Chapter 6 addresses the factors that can limit heterologous protein expression 
in P. pastoris. Among them, individual codon usage (ICU) and codon context (CC) 
has been implicated as important parameters determining protein expression 
efficiency. Thus, in order to rationally design synthetic genes with optimal ICU and 
CC, three different computational approaches were developed. The mathematical 
formulation and computation procedures are presented in detail. It is noted that the 
content of this chapter has been submitted for publication in the online journal of 
BMC Systems Biology. 
Chapter 7 compares the differences in ICU and CC distributions between 
high-expression genes and all genes in the genome to highlight the relevance of 
selecting high-expression genes for establishing the host’s preferred codon usage 
patterns. The various optimization methods developed in Chapter 6 were then applied 
to study the relative effects of ICU and CC optimization on gene expression. The 
performance of the various computational approaches was evaluated using in silico 
cross-validation and in vivo experiments of P. pastoris heterologous protein 
expression. It is noted that the content of this chapter has been submitted for 
publication in the online journal of BMC Systems Biology. 
Chapter 8 summarizes the contributions made in this thesis and highlights 
future perspectives of systems biotechnology research. 
 
 




Chapter 2. Overview of systems biotechnology 
 
2.1. The advent of systems biology 
The variety of physiological behaviors observed in a living cell is a result of complex 
interactions between biomolecules. These interactions can be conceptually organized 
and represented as biological networks which can be classified into five types: 
transcription factor binding network, protein-protein interaction network, protein 
phosphorylation network, metabolic network, and genetic interaction network (Zhu et 
al, 2007). The advent of high-throughput experimental technology has enabled the 
generation of huge amounts of biological information to study these biological 
networks on a large scale from a systems perspective, commonly referred to as 
“systems biology” (Kitano, 2002). Systems biology adopts a holism paradigm that 
studies biological components in the living organism as a composite whole, in 
contrast to the conventional reductionist approach which examines them individually. 
The key advantage of the systems biological approach is its ability to elucidate non-
intuitive “emergent properties” which cannot be predicted by isolated studies of 
individual biological parts, thus providing insights into the idiosyncratic physiological 
behavior of living systems under various kinds of perturbation  (Butcher et al, 2004). 
A requisite skill for embarking on a systems biology study is the ability to 
process and interpret the enormous amount of relevant biological data generated by 
wet-lab experiments. Efficient handling of such data may require specialized 
computational techniques. In this aspect, the field of bioinformatics plays a pertinent 
role in exploring the application of computer science and information technology to 




facilitate data mining and processing. Subsequently, the processed biological 
information can be incorporated into the in silico modeling and simulation of 
physiological behavior, which is the primary goal of computational biology. 
Accordingly, the systems biological framework typically involves the interaction 
between bioinformatics and computational biology to create biologically accurate in 
silico models of living systems using various computational algorithms. The 
computational simulations of cellular behavior will then be compared with wet-lab 
experimental observations to systematically improve the accuracy of the in silico 
model. Findings from in silico modeling can also result in novel hypotheses that 
drives further experimental works, leading to an iterative knowledge discovery 
process in systems biology (Figure 2.1). As such, this thesis endeavors to harness the 
utility of systems biology to gain a deeper understanding of cellular behavior through 
the development of rational analytic framework. Through extensive use of 
computational methods for the modeling and simulation of physiological behavior, 
this work aims to gain a better understanding of micro-organisms’ cellular 
metabolism, thereby leading to better protocols of engineering the microbial cell 
factories for biotechnological applications. 





Figure 2.1. The systems biology framework. An integration of information, systems 




2.2. Application of systems biology to biotechnology 
The scientific approach of systems biology has been widely used for the discovery of 
novel biomolecular interactions and the mechanisms by which these interactions 
modulate cellular physiology (Butcher et al, 2004; Kitano, 2002). The translation of 
this scientific knowledge into state-of-the-art technologies for industrial production of 
value-added biochemicals is the embodiment of biotechnology. A key objective in 




biotechnology is to develop high-yield and low-cost bioprocesses through 
microorganism strain improvement. The traditional approach towards strain 
improvement involves random mutagenesis followed by screening of mutants to fish 
out high performance strains (Parekh et al, 2000). This cost-efficient approach has 
gained widespread popularity in the industry. However, it does not provide a 
fundamental understanding of cellular physiology which is required for the rational 
design of genetic engineering strategies that can result in the creation of more 
optimized microbial strains. Hence, the timely inception of systems biology led to the 
emergence of systems biotechnology which harnesses the power of high-throughput 
experimental techniques coupled with in silico modeling and analyses to rationally 
engineer the microorganism (Lee et al, 2005b). The genetic engineering of microbes 
for biotechnological applications, also known as “metabolic engineering”, typically 
involves the manipulation of metabolic genes to alter cellular metabolism for the 
purpose of heterologous protein production, substrate range extension, 
production/degradation of xenobiotics, improved cell tolerance and/or enhanced 
productivity (Nielsen, 2001). To achieve these goals, systems biotechnology employs 
computational modeling methods to gain insights into fundamental cellular processes 
that determine the organism’s overall physiology. 
 
2.3. In silico modeling of biological systems 
Computational simulation of cellular behavior provides a cost-effective way of testing 
the outcomes of different metabolic engineering strategies. These “dry-lab” in silico 
experiments complement the wet-lab experiments, providing a rational approach 
towards biological system engineering (Lee et al, 2005b). Depending on the approach 
of model formulation, the resulting in silico model can either be a mathematical 




model composed of mathematical equations that can be solved using a computational 
solver, or a computational model composed of stochastic discrete entities which can 
be computed to simulate biological phenomena (Fisher & Henzinger, 2007). In this 
thesis, the former approach is adopted to take advantage of the numerous 
computational tools which have been developed to solve different forms of complex 
mathematical equations that describe various aspects of the living system. 
Depending on the level of abstraction, the mathematical models in systems 
biology can be classified as interaction-based, constraints-based or mechanism-based 




Figure 2.2. Types of mathematical model in systems biology. 
 
 
The most elementary form of biological network models that only account for 
the presence or absence of interactions between biomolecules are interaction-based 
models. Graph theory is the key mathematical tool used to quantify and analyze 




network properties in interaction-based models. This concept has allowed the 
discovery of scale-free biological networks whereby most biomolecules have very 
few interaction partners with only a handful of unique ones known as “hubs” that can 
interact with multiple targets (Albert, 2005; Barabasi & Oltvai, 2004). When the 
directionality of the interactions is considered, the bow-tie structure which consists of 
a highly connected core network forming the interface between incoming and 
outgoing sparsely connected clusters has been observed (Ma & Zeng, 2003). Such 
scale-free and bow-tie structural properties have often been used to explain the 
robustness of biological systems (Csete & Doyle, 2004; Kitano, 2004). 
If the strength and stoichiometry of interactions are also taken into account, 
the interaction-based model can become a constraints-based model (Stelling, 2004). 
Reaction stoichiometry and reversibility are invariant physicochemical properties. By 
incorporating these stoichiometric and reversibility constraints in the mathematical 
model, the constraints-based model will be able to capture the range of feasible 
physiological states that obey the physical and chemical laws. The specific rates, also 
known as fluxes, of individual reactions can be graphically represented as a “flux 
cone” (Figure 2.2) (Wagner & Urbanczik, 2005). The constraints-based modeling 
approach is especially suitable for describing metabolic flux distribution. In cellular 
metabolism research, constraints-based analysis, also called “flux balance analysis”, 
has been widely used and numerous tools have been developed to implement the 
constraints-based model (Raman & Chandra, 2009). 
When concentration variation and activation/inhibition of biomolecules in the 
form of reaction kinetics are considered in addition to stoichiometric constraints, the 
resultant model is mechanism-based (Stelling, 2004). Unlike interaction-based and 
constraints-based models which only capture the steady-state behavior, mechanism-




based models can describe interesting transient behavior such as metabolic 
oscillations. Such models are usually highly nonlinear due to the complex differential 
equations which can take on the forms of mass action law, Michaelis-Menten kinetics 
or Hill equation (Klipp et al, 2005). Therein lies the challenge in mechanism-based 
modeling where substantial condition-specific experimental data is required to 
estimate the kinetic parameters (Costa et al, 2011). Nonetheless, numerous kinetic 
modeling studies have been published, many of which can be found in the online 
repository of BioModels Database1 (Le Novere et al, 2006; Li et al, 2010). 
In this thesis, the constraints-based modeling approach is adopted as it can 
provide sufficient details for describing the cellular metabolism of P. pastoris while 
circumventing the issue of experimental data scarcity which hinders the process of 
kinetic parameter estimation in mechanism-based modeling. 
 
2.4. Constraints-based flux analysis  
The physiology of an organism can be characterized by defining the physicochemical 
constraints that are imposed on the system (Hartwell et al, 1999). The constraints-
based flux analysis exploits this concept to elucidate cellular metabolism. In general, 
the constraints imposed on the biological system can be physicochemical, spatial, 
environmental and/or regulatory constraints (Price et al, 2004). The introduction of 
relevant constraints defines a multidimensional solution space that captures all 
achievable metabolic states. 
 
                                                 
1 http://www.ebi.ac.uk/biomodels-main/ 




2.4.1. The basic constraints-based flux analysis framework 
Cellular metabolism can be described in terms of the relative abundance of 







i metabolite∀= ∑  
The variable iC  refers to the concentration of metabolite i , usually measured in units 
of millimole per gram dry cell weight (mmol/gDCW); jv  refers to the flux or specific 
rate of metabolic reaction j , usually measured in units of millimole per gram dry cell 
weight per hour (mmol/gDCW-hr); ijS  refers to the stoichiometric coefficient of 
metabolite i  involved in reaction j . Under the pseudo-steady-state assumption, there 
is no accumulation of metabolites resulting in a linear stoichiometric constraint 
0=∑
j
jij vS  which is the key feature of constraints-based flux analysis. This 
constraint can also be expressed in matrix form 0Sv =  where S  is known as the 
stoichiometric matrix and v  is the flux vector. The assumption of pseudo-steady-state 
is usually valid for cellular metabolism since the time constant of metabolic reactions 
(in the order of milliseconds to tens of seconds) is significantly less than that of 
transcriptional regulation (in the order of minutes) and cell growth (in the order of 
hours to days) (Covert et al, 2001). 
 





Figure 2.3. The stoichiometric constraint. For the above toy metabolic network, the 
stoichiometric constraint can be constructed in two mathematically equivalent forms. 
 
For any metabolic network, the pseudo-steady-state stoichiometric constraint 
can be formulated in two ways (Figure 2.3). In the alternative expression of the 
stoichiometric constraint, i.e. bSv = , the b  vector can consist of nonzero variables 
corresponding to rate of exchange of extracellular metabolites. Therefore, b  
represents the cell’s environment as determined by the culture media. However, the 







. Therefore, to avoid confusion, the stoichiometric constraint will 
only be formulated as 0Sv =  in this thesis. Furthermore, the stoichiometric matrix is 
always formulated such that the sign convention for any external metabolite exchange 
rate is always negative for uptake into the cell and positive for secretion out of the cell. 
Consequently, the stoichiometric coefficient for all external metabolites will be −1. 




For example in Figure 2.3, the stoichiometry for metabolite “Axt” will be changed to 
−1 to follow the stipulated sign convention. 
Although stoichiometric constraints analysis has been used to check 
experimental data consistency and calculate theoretical yields of microbial 
fermentation (Papoutsakis & Meyer, 1985), the metabolic system defined by these 
constraints is still difficult to interpret due to multidimensionality. To better 
understand the physiological implications of this multidimensional feasible solution 
space, several analysis methods, mostly based on linear programming, have been 
proposed. 
Linear programming (LP) is a mathematical method for solving a system of 
linear equations to achieve the best value for a pre-specified objective function. In the 
context of constraints-based flux analysis, LP is used to find the metabolic flux 
distribution which optimizes a particular cellular objective, mathematically 
formulated as: 
 (P1) max ∑=
j
jj vcZ  
  s.t. ivS
j
jij metabolite0 ∀=∑  
   jvvv jjj reaction
maxmin ∀≤≤  
The parameters minjv  and 
max
jv  impose the lower and upper limits on the flux of 
reaction j  respectively; Z  defines the cellular objective as a linear function of all the 
metabolic fluxes where the relative weight of each is determined by the coefficient jc . 
The above mathematical formulation of constraints-based flux analysis is also called 
“flux balance analysis” since the reaction fluxes are balanced according to the 
stoichiometric constraint 0=∑
j
jijvS  (Orth et al, 2010). However, the name of 




“constraints-based flux analysis” is preferred in this thesis as it reflects the nature of 
the modeling approach while “flux balance analysis” only refers to just one specific 
constraint in the formulation. 
The earliest application of LP to examine the stoichiometric constraints of 
cellular metabolism was performed on the metabolic network of adipocytes to study 
the metabolic requirements of triacylglyerol synthesis by maximizing triacylgylcerol 
yield (Fell & Small, 1986). Nonetheless, the more useful form of LP formulation aims 
to predict cell growth by maximizing biomass synthesis, mathematically defined as 
biomassvZ = , based on the assumption that the organism is naturally evolved to achieve 
maximal growth rate. The biomass production reaction in this conventional form of 
constraints-based flux analysis is a pseudo metabolic reaction which describes the 
average stoichiometric consumption of biological building blocks for cell growth. By 
constraining the uptake of glucose (e.g. setting 10max_
min
_ −== uptakeglcuptakeglc vv  
mmol/gDCW-hr) and maximizing cell growth, the constraints-based flux analysis 
predicts the biomass yield under the specified environmental condition which can be 
easily verified by cell culture experiments. It is noted that maximizing cell growth rate 
in constraints-based flux analysis can be generally interpreted as biomass yield 
maximization (Schuster et al, 2008). 
The “cell growth maximization” implementation of constraints-based flux 
analysis was first successfully used to quantitatively predict cell growth and by-
product secretion profiles in Escherichia coli (Varma & Palsson, 1994). Following 
this, growth maximization constraints-based flux analysis has become the de facto 
method of analyzing steady-state metabolic models such that the construction of 
cellular biomass synthesis reaction becomes an integral part of the in silico analysis 
(Feist & Palsson, 2010). However, in cases where maximizing biomass production 




may not be an appropriate cellular objective, alternative objective functions have to be 
defined for constraints-based flux analysis. The rationale of adopting the alternative 
objectives are generally based on various hypotheses: ATP yield maximization and 
redox potential minimization assume evolution towards maximal energetic efficiency; 
minimization of reaction steps assumes evolution towards minimal expression of 
metabolic enzymes to achieve cell growth; and carbon source uptake minimization 
assumes evolution towards efficient utilization of carbon source for cell growth 
(Knorr et al, 2007; Schuetz et al, 2007). These alternative objectives have been 
validated by the Bayesian approach of comparing in silico predictions with wet-lab 
cell culture data (Knorr et al, 2007) and the evaluation of predictive fidelity of flux 
split ratios with respect to 13C isotope labeling experimental data (Schuetz et al, 2007). 
While the alternative objective functions could be valid under certain experimental 
conditions, the maximization of growth rate remains the most relevant and intuitive 
cellular objective for checking the prediction accuracy of in silico metabolic models. 
 
2.4.2. Exploring metabolic capabilities using constraints-based flux analysis 
Various forms of analyses could be carried out under the constraints-based flux 
analysis framework to investigate the metabolic capabilities of an organism. One of 
the earlier studies demonstrated the characterization of all feasible metabolic flux 
distributions under various nutrient uptake conditions using a phenotype phase plane 
(Edwards et al, 2002). Based on the concept of shadow price from mathematical 
optimization, the phenotype phase diagram is constructed by perturbing the 
constraints of carbon source and/or oxygen uptake over a range of values to obtain the 
maximum cell growth for each perturbed condition. The phenotypic phase plane 
analysis has been used to determine optimal growth characteristics and the effects of 




gene deletions in E. coli (Edwards et al, 2001; Edwards & Palsson, 2000). Following 
the development of phenotypic phase plane analysis, the flux variability analysis was 
also proposed to characterize the set of alternate optimal solutions of the LP problem 
in conventional constraints-based flux analysis (Mahadevan & Schilling, 2003). Flux 
variability analysis has been used to explore the range of metabolic flux distributions 
that can lead to optimum cell growth in E. coli (Reed & Palsson, 2004) and its 
concept has been further extended to identify correlated sets of reactions using the 
Flux Coupling Finder (Burgard et al, 2004). 
An alternative method for characterizing metabolic capacity utilizes Monte 
Carlo sampling to obtain a distribution of flux values for each metabolic reaction 
(Wiback et al, 2004). In a previous study which analyzed the human mitochondrial 
metabolic network, the flux space sampling method was able to show that the 
experimentally observed reduced activity of pyruvate dehydrogenase under diabetic 
condition could be attributed to metabolic flux balancing rather than some unknown 
regulatory mechanisms (Thiele et al, 2005). The concept of flux space sampling has 
also been developed into the “k-cone analysis” method which can be used to identify 
the solution space for the kinetic parameters used in dynamic modeling (Famili et al, 
2005). 
 
2.4.3. Strain improvement using constraints-based flux analysis 
The applicability of constraints-based flux analysis to predict microorganisms’ growth 
characteristics has been demonstrated in numerous studies over the past decade 
(Raman & Chandra, 2009). Given its capability to mimic in vivo metabolic behavior, 
constraints-based flux analysis presents itself as a useful computational platform to 
conduct in silico experiments to test the effect of genetic manipulations on cellular 




metabolism. The essentiality of genes, reactions or metabolites can be easily 
evaluated in constraints-based flux analysis through in silico knockout analysis by 
constraining the flux values of relevant reactions to zero. A more sophisticated 
analysis of identifying gene knockout targets for strain improvement has been 
presented in the OptKnock method based on a bilevel programming framework 
(Burgard et al, 2003; Pharkya et al, 2003). While gene knockout targets can also be 
identified in conventional constraints-based flux analysis using the brute-force 
approach where the LP (P1) is solved repeatedly under the some 0=jv  constraints 
for various combinations of j , OptKnock is more effective and systematic in the 
identification of gene knockout candidates by solving a mixed-integer linear 
programming (MILP) problem. Following the successful application of OptKnock to 
identify experimentally validated gene knockout targets for amino acid 
overproduction (Pharkya et al, 2003), the bilevel programming framework was further 
developed into OptStrain for identifying both gene insertion and deletion candidates 
(Pharkya et al, 2004) and OptReg for selecting relevant metabolic enzymes to be 
activated or inhibited (Pharkya & Maranas, 2006). 
 
2.5. Genome-scale metabolic model (GSMM) 
2.5.1. GSMM reconstruction 
The utility of constraints-based flux analysis in biological studies hinges upon the 
quality of the metabolic model. A model which accounts for all possible biological 
capabilities of the organism of interest will be able capture all relevant physiological 
behavior observed in the wet-lab experiments. Accordingly, a metabolic model 
constructed based on the genomic catalogue of biological functions will be the most 




useful. This process of building a metabolic model from an organism’s genome is 
often known as “model reconstruction”; the resultant model is then called a genome-
scale metabolic model (GSMM) (Durot et al, 2009). Due to the level of details 
captured in the GSMM, such a model can be exploited for numerous applications 
including (1) contextualization of high-throughput data, (2) guidance of metabolic 
engineering, (3) directing hypothesis-driven discovery, (4) interrogation of multi-
species relationships and (5) network property discovery (Oberhardt et al, 2009). 
To date, more than 50 GSMMs have been reconstructed for over 30 species of 
organisms from all three domains of life: Archaea, Bacteria and Eukarya (Feist et al, 
2009). A comprehensive list of the available reconstructions can be found online2. 
With such extensive efforts in GSMM reconstruction, a comprehensive protocol has 
recently been published to aid the process of building GSMMs (Thiele & Palsson, 
2010). The typical reconstruction task begins with the processing of genomic data to 
identify metabolic functions encoded by the genes. In this step, genome databases 
such as Genomes OnLine Database3 (Pagani et al, 2012), UCSC Genome Browser4 
(Dreszer et al, 2012) and Ensembl 5  (Hubbard et al, 2002) are vital sources of 
information. The functional annotations the genes provide the necessary information 
to build the list of relevant metabolic reactions in the draft network model. The 
protein sequences can also be used to automate the short-listing of metabolic reactions 
through the use of BLAST sequence comparison (Altschul et al, 1990). Subsequently, 
the draft can be manually curated to verify the accuracy of various aspects of the 
metabolic reactions including enzyme cofactor specificity, reaction directionality and 
reaction subcellular localization. 









As the application of GSMM to analyze cellular metabolism is gaining 
popularity in the recent decade, several tools have been developed to aid the model 
reconstruction process. Computational tools that are capable of automating the 
reconstruction of metabolic network from an organism’s genome include 
AUTOGRAPH (Notebaart et al, 2006), metaSHARK (Pinney et al, 2005) and the 
KEGG Automatic Annotation Server (Moriya et al, 2007). In general, these tools 
utilize some form of gene sequence comparison to infer metabolic functions based on 
sequence homology. Although these tools have been claimed to expedite the 
reconstruction workflow, the most time-consuming step of manual curation is still 
indispensable to improve the quality of the GSMM. Therefore, instead of utilizing 
these tools to automate the reconstruction of the draft model, this thesis adopts a more 
manual approach towards screening the microbe’s genome and identifying relevant 
metabolic reactions to achieve the reconstruction of a high-quality GSMM. Once the 
GSMM has been adequately refined, it can be validated with relevant experimental 
data. 
 
2.5.2. GSMM validation 
After a series of manual revisions, the resultant GSMM will be used to simulate cell 
growth whereby the in silico predictions can be validated with experimental data to 
evaluate the quality of the model. Due to the assumption of steady-state under the 
constraints-based flux analysis framework, the chemostat experimental set-up which 
operates like a continuous stirred tank chemical reactor will be most relevant to 
generate the data for model validation. Chemostat experiments are usually conducted 
using a minimal medium as the feed. Minimal media are solutions composed of all the 
necessary nutrients required for cell growth, albeit with one component that has the 




limiting concentration. In the design of minimal media, the elemental composition of 
the organism can be considered to estimate the required media composition. The 
composition of a commonly used minimal medium, the M9 medium, is shown in 
Table 2.1 (Sambrook & Russell, 2001). Comparing the carbon-to-nitrogen ratio (C:N 
= 1:0.28) and carbon:phosphate ratio (C:P = 1:0.33) of M9 medium with that of the 
biomass content of microbes (i.e. C:N = 1:0.2; C:P = 1:0.02) (Nielsen & Villadsen, 
1994), it is clear that the carbon source is limiting. 
 
Table 2.1. Composition of M9 minimal medium. 
 
Components g/L mM 
Glucose (C6H12O6) 2 11.1 
Na2HPO4⋅7H2O 12.8 47.7 
KH2PO4 3 22.0 
NaCl 0.5 8.6 
NH4Cl 1 18.7 
MgSO4 0.24 2.0 
CaCl2 0.01 0.1 
 
 To simulate the chemostat cell culture fed with the M9 minimal medium in 
constraints-based flux analysis, the uptake rates of all carbon sources are set to zero 
except for glucose which is constrained to the experimentally measured values. By 
solving (P1) with cell growth as the objective to be maximized, an in silico flux 
distribution solution will be generated. The predicted values of cell growth, gaseous 
exchange and by-product secretion rates are then compared with the experimental 
data to validate the adequacy of the GSMM. 
 




Chapter 3. Pichia pastoris genome-scale metabolic model 
reconstruction 
 
3.1. Methylotrophic yeast Pichia pastoris 
Most of Pichia pastoris strains are naturally found in exudates and rotten wood of 
trees (Dlauchy et al, 2003). In this native habitat, pectin, a cell wall polysaccharide 
that is important for plant growth, is being degraded to form methanol by pectinolytic 
microbes such as Clostridium, Erwina and Pseudomonas through the activity of 
pectin methylesterase enzyme (Schink & Zeikus, 1980). The methanol-rich 
environment allows P. pastoris to find its niche as it is a methylotrophic yeast that has 
the ability to assimilate methanol for cell growth. Regarding the yeast’s taxonomy, P. 
pastoris has been proposed to be renamed Komagataella pastoris due to its 
phylogenetic differences in ribosomal RNA from other Pichia species (Yamada et al, 
1995). However, due to widespread use of the former name and some doubts on the 
quality of phylogenetic data analysis used to reclassify P. pastoris as K. pastoris 
(Kurtzman, 2000), the former name will be used in this thesis. 
P. pastoris has gained popularity as an expression host for producing 
heterologous proteins. The methylotrophic yeast has several advantages over other 
eukaryotic and prokaryotic expression systems including (1) capability of high cell 
density fermentation coupled with rapid growth rate, (2) high recombinant protein 
productivity in an almost protein-free medium due to low secretion of native proteins, 
(3) ability to assimilate methanol which can also induce the alcohol oxidase (AOX) 
promoter to express the heterologous protein, (4) capability of post-translational 
modifications such as glycosylation, disulfide bond formation and proteolysis, (5) 




availability of P. pastoris in commercial expression kits and (6) ease of cultivation 
and genetic manipulation using experimental protocols similar to the well-
characterized S. cerevisiae system (Cereghino & Cregg, 2000; Macauley-Patrick et al, 
2005). Furthermore, with recent advances in glycosylation engineering to achieve 
complex humanized N-linked glycosylation of recombinant proteins, the P. pastoris 
expression system can be a competent host for producing high-efficacy therapeutic 
proteins for human consumption (Chiba & Akeboshi, 2009; Hamilton & Gerngross, 
2007; Li et al, 2006). 
Although many experimental studies have been performed to demonstrate the 
utility of P. pastoris for heterologous protein expression, little has been done to 
characterize its metabolic behavior, a fundamental aspect of yeast physiology that can 
affect its performance as a microbial cell factory. Hence, a genome-scale metabolic 
model (GSMM) was reconstructed to describe the cellular metabolism of P. pastoris. 
The reconstruction and validation procedure of the P. pastoris GSMM is detailed in 
the following sections. 
 
3.2. Reconstruction of P. pastoris genome-scale metabolic model 
Cellular metabolism depicts the phenotype of an organism. The possible range of 
metabolic states exhibited by the cell is in turn determined by the genes found in the 
genome. Therefore, by constructing a model which accounts for enzymatic reactions 
associated with all metabolic genes found in the genome, the organism’s full 
metabolic potential can be accurately captured. Such a genome-scale metabolic model 
(GSMM) can be reconstructed according to the workflow illustrated in Figure 3.1. 
 





Figure 3.1. Reconstruction schema for P. pastoris GSMM. Information from published 
genome of P. pastoris and various metabolic pathway databases, including MetaCyc (Caspi et 
al, 2010), BRENDA (Chang et al, 2009) and ExPASy ENZYME (Bairoch, 2000), were used 
for the reconstruction and manual curation of the metabolic model. 
 
 




3.3. Manual curation and gap-filling 
After obtaining the initial draft metabolic model from information mining of the P. 
pastoris genome and metabolic pathway database, manual curation was performed to 
update the model with all relevant species-specific metabolic reaction information. 
For example, the thiamine biosynthetic pathway in the model was modified to reflect 
yeast-specific pathway organization as reported in recent studies (Chatterjee et al, 
2008; Zeidler et al, 2003). It is noted that this pathway had been incorrectly 
represented in the iMM904 metabolic model of S. cerevisiae which assumes that 
cytosolic thiamine pyrimidine (4-amino-5-hydroxymethyl-2-methylpyrimidine or 
HMP), a precursor for thiamine biosynthesis, is derived from 5-aminoimidazole 
ribonucleotide, which is a mechanism only associated with bacteria (Lawhorn et al, 
2004; Newell & Tucker, 1968). The appropriate mechanism for yeasts, as reported in 
a recent study (Ishida et al, 2008), involves histidine and pyridoxal 5’-phosphate as 
precursors for the formation of HMP (Figure 3.2). In the metabolic model, the 
stoichiometric requirements of key precursors for HMP production are specified 
accordingly even though the chemical equations may not be redox balanced due to the 
lack of experimental evidence on the exact reaction mechanism (Ishida et al, 2008). 
Nonetheless, qualitative predictions of gene, reaction and metabolite essentiality in 
the pathway is still possible since thiamine is a trace component of cellular biomass 
with a very small composition value as shown previously (Harder & Brooke, 1990). 
Consequently, errors due to the chemical imbalance of HMP biosynthesis will not 
have a significant impact on the quantitative prediction of cellular phenotype. 
 





Figure 3.2. Thiamine biosynthetic pathway. 
 
Apart from modifying existing reactions in the draft model to reflect P. 
pastoris-specific metabolism, new reactions may be added to the model to complete 
essential biosynthetic pathways. This step of filling up metabolic pathway gaps is 
known “gap-filling”. While a computational tool for automated gap-filling is available 
(Satish Kumar et al, 2007), the output generated by the software will still require a 
manual check to identify the most suitable enzymatic reactions to be added. Therefore, 
the manual approach of gap-filling was performed instead. The constraints-based flux 
analysis can be used to simulate the utilization of various metabolic pathways to 
identify metabolic gaps. Subsequently, appropriate reactions from pathway database 
can be added to fill the gaps. In the initial draft of the metabolic model, essential 
reactions such as 2-aminoadipate transaminase (EC 2.6.1.39) and deoxyadenylate 
kinase (EC 2.7.4.11) were missing due to absence of the corresponding genes in the P. 
pastoris genome annotation. They were then added to the model based on the 
information provided by the MetaCyc database (Caspi et al, 2010). 
Following the curation of metabolic reactions, the GSMM is updated to reflect 
the appropriate subcellular localization of the enzymes. Since in vivo data of 




metabolic enzymes localization in P. pastoris is not available, the cellular 
compartments of metabolic reactions were assigned based on the 
compartmentalization information in presented in the GSMM of S. cerevisiae (Mo et 
al, 2009). In cases where the required information is not available, the web-based 
software WoLF PSORT6 (Horton et al, 2007), which predicts subcellular localization 
based on protein sequence analysis, is used to aid the assignment of compartments. 
The compartments present in the P. pastoris GSMM include cytosol, endoplasmic 
reticulum, extracellular matrix, peroxisome, Golgi apparatus, mitochondrion, nucleus 
and vacuole, which are indicated by the labels “[c]”, “[r]”, “[e]”, “[x]”, “[g]”, “[m]”, 
“[n]” and “[v]”. 
 
3.4. GSMM biomass composition 
Under the constraints-based flux analysis framework, cellular metabolism is usually 
simulated by maximizing cell growth. In order to predict the experimentally observed 
phenotype, it is crucial to accurately account for all the necessary growth 
requirements under the biomass synthesis reaction in the GSMM. The information for 
constructing the biomass synthesis reaction can be obtained via experimental analysis 
of cellular biomass. In the case of P. pastoris GSMM, existing data published in 
several experimental studies is utilized to calculate the composition of carbohydrate, 
protein, lipid and nucleotide components in the cell’s biomass. The molecular weight 
of each biomolecule can be obtained from the NCBI PubChem Compound Database7. 
 
                                                 
6 http://wolfpsort.org/ 
7 http://pubchem.ncbi.nlm.nih.gov/  




3.4.1. Overall cellular composition 
A detailed biomass macromolecular and elemental composition analysis has recently 
been conducted on P. pastoris grown at different levels of oxygen abundance 
(Carnicer et al, 2009). The cellular composition data for the wild-type strain grown 
under 21% oxygen supply is used for constructing the biomass reaction (Table 3.1). 
 










Inorganic components which constitute about 7.3% of the total dry cell weight 
(DCW) are not accounted for in the biomass reaction as they have no impact on the 
carbon flux distribution. In the following subsections, the precursor requirement for 
each of the organic macromolecules shown in Table 3.1 is further analyzed. 
 
3.4.2. Amino acid composition 
The amino acid content in proteins has been experimentally determined (Carnicer et al, 
2009). In the experiment, the composition of aspartate cannot be distinguished from 
that of asparagines; this is also the case for glutamine and glutamate. Thus, equal 
distribution is assumed for these two pairs of amino acids. Furthermore, the 
composition of ornithine, found to constitute 1.53% of the proteins, was ignored since 
it is not a proteinogenic amino acid. Based on the average protein molecular weight of 
111.5 g/mol, the amino acid composition (in units of mmol/gDCW) can be calculated 




using the molecular weight of the amino acids excluding the weight of the water 
molecule that was lost during the formation of peptide bonds (Table 3.2). 
 
Table 3.2. Calculation of amino acid composition. 
 
Amino acid Mol % MW mmol/g Protein mmol/gDCW
Ala 10.68 71.078 0.958 0.378 
Arg 6.74 156.186 0.605 0.239 
Asn 4.39 114.103 0.394 0.156 
Asp 4.39 115.087 0.394 0.156 
Cys 0.15 103.143 0.013 0.005 
Gln 9.28 128.129 0.832 0.329 
Glu 9.28 129.114 0.832 0.329 
Gly 7.12 57.051 0.639 0.252 
His 1.79 137.139 0.161 0.063 
Ile 4.12 113.158 0.370 0.146 
Leu 6.99 113.158 0.627 0.248 
Lys 6.33 128.172 0.568 0.224 
Met 0.77 131.196 0.069 0.027 
Phe 3.03 147.174 0.272 0.107 
Pro 3.67 97.115 0.329 0.130 
Ser 6.43 87.077 0.577 0.228 
Thr 5.77 101.104 0.518 0.204 
Trp 1.40 186.210 0.126 0.050 
Tyr 2.13 163.173 0.191 0.075 
Val 5.58 99.131 0.501 0.198 
 
 
3.4.3. Carbohydrates composition 
Apart from glycogen and trehalose, the composition of the other carbohydrate 
constituents, which was not measured in detail (Carnicer et al, 2009), were lumped 
together as β-D-glucan (13BDglcn). In the GSMM, β-D-glucan and glycogen 
synthesis were modeled in the form of “udpg[c] → 13BDglcn[c] + h[c] + 
udp[c]” and “udpg[c] → glycogen[c] + h[c] + udp[c]”, respectively. The 
metabolites representing the β-D-glucan and glycogen are monomers of the 
carbohydrate polymers. Hence, in the calculation of their compositions, the molecular 




weight of the monomer that excludes the weight of water lost during polymerization 
is used (Table 3.3). 
 
Table 3.3. Carbohydrate composition. 
 
Carbohydrate g/100 gDCW MW mmol/gDCW 
13BDglcn 27.75 163.149 1.711 
Glycogen 11.26 163.149 0.694 
Trehalose 0.33 342.296 0.0096 
 
 
3.4.4. DNA composition 
From the genome sequencing of P. pastoris, the G+C content of the DNA was found 
to be 41.1% (De Schutter et al, 2009). Since DNA is a complementary double 
stranded macromolecule, the amount of adenine and cytosine will be equal to that of 
thymine and guanine, respectively. As such, based on the DNA macromolecular 
composition of 0.1 g/gDCW (Carnicer et al, 2009), the cellular composition of each 
nucleotide can be calculated (Table 3.4). 
 
Table 3.4. DNA composition. 
 
DNA MW mol/mol DNA g/mol DNA mmol/gDCW 
dAMP 329.21 0.2945 96.951 0.0013 
dCMP 305.18 0.2055 62.715 0.0009 
dGMP 345.21 0.2055 70.940 0.0009 
dTMP 320.19 0.2945 94.297 0.0013 
 
 
3.4.5. RNA composition 
The average macromolecular RNA composition of P. pastoris was found to be similar 
to that of S. cerevisiae (Carnicer et al, 2009). Due to lack of detailed experimental 
data, the cellular composition of each RNA component is assumed to be similar to 




that of S. cerevisiae reported in a GSMM reconstruction study (Table 3.5) (Förster et 
al, 2003). 
 









3.4.6. Lipid composition 
Detailed analysis of membrane lipid composition of P. pastoris has been conducted 
(Wriessnegger et al, 2009). The three main sub-classes of lipids considered in the 
biomass synthesis reaction are fatty acids, phospholipids and sterols. As 
phospholipids consist of fatty acid chains of varied lengths, the average chain length 
of fatty acids is first estimated before calculating the composition of individual 
phospholipids (Table 3.6). 
 
Table 3.6. Fatty acid composition. 
 
Fatty acids (FA) g/g FA MW mmol/g FA mol % FA 
Hexadecanoate (n-C16:0) 0.155 255.42 0.607 0.167 
Hexadecenoate (n-C16:1) 0.055 253.40 0.22 0.060 
Octadecanoate (n-C18:0) 0.034 283.47 0.12 0.033 
Octadecenoate (n-C18:1) 0.339 281.45 1.20 0.331 
Octadecadienoate (n-C18:2) 0.288 279.44 1.03 0.283 
Octadecadienoate (n-C18:3) 0.129 277.42 0.465 0.128 
 
Based on the computed data (Table 3.6), the fatty acids were calculated to 
have an average chain length of 17.5 and molecular weight of 274.4 g/mol. Using this 




information, the average molecular weights and biomass composition of the 
phospholipids can be calculated (Table 3.7). 
 
Table 3.7. Phospholipid composition. 
 
Phospholipid g/g Lipid Core MW No. of FA mmol/gDCW
Triglycerol 0.572 173.10 3 0.0356 
Cardiolipin 0.003 508.22 4 0.0001 
Phosphatidic acid 0.001 226.08 2 0.00008 
Phosphatidylcholine 0.100 312.23 2 0.00720 
Phosphatidylethanolamine 0.052 269.15 2 0.0039 
Phosphatidylserine 0.001 383.29 2 0.00008 
Phosphatidylinositol 0.003 388.22 2 0.0002 
 
The mass composition of sterol was measured as a ratio of protein mass 
(Wriessnegger et al, 2009). Therefore, the overall protein composition of 0.395 g 
protein/gDCW (Carnicer et al, 2009) and sterol composition of 0.268 g sterol/g lipid 
(Carnicer et al, 2009) were used to calculate the individual sterol compositions (Table 
3.8). 
 
Table 3.8. Sterol composition. 
 
Sterol µg/mg protein g/g sterol MW mmol/gDCW 
Episterol 0.3 0.02 398.66 0.0007 
Ergosterol 17.7 0.927 396.65 0.0388 
Fecosterol 0.3 0.02 398.66 0.0007 
Lanosterol 0.1 0.005 426.72 0.0002 
Zymosterol 0.7 0.04 384.64 0.002 
 
 
3.4.7. Growth associated ATP requirement 
Hitherto, the energy required for the synthesis of macromolecules such as proteins 
and nucleic acids has not been considered. The polymerization of individual amino 
acids (nucleotides) into proteins (DNA strands) requires energy which can be 




expressed in the form of ATP. The average ATP requirement for polymerization per 
unit weight of proteins and nucleic acids has been estimated for S. cerevisiae 
(Verduyn, 1991). Therefore, the growth associated ATP requirement for P. pastoris is 
calculated to be around 16.75 mmol ATP/gDCW (Table 3.9). 
 
Table 3.9. Growth associated ATP requirement. 
 
Polymer g/gDCW mmol ATP/g polymer mmol ATP/gDCW 
Protein 0.395 37.7 14.89 
RNA 0.070 26.0 1.83 
DNA 0.001 26.0 0.04 
 
 
3.4.8. Other essential biomass components 
Certain cellular components, such as coenzyme A, flavin adenine dinucleotide (FAD) 
and nicotinamide adenine dinucleotide (NAD), are cofactor metabolites that are 
constantly being regenerated. Although they are not synthesized as much as the 
aforementioned biomass components, they are still essential for cell growth. Hence, 
the composition of these trace components will be arbitrarily set to a small amount, i.e. 
10-5 mmol/gDCW, to account for their essentiality. The list of trace components 
included in P. pastoris GSMM is assumed to be similar to that in the S. cerevisiae 
GSMM (Table 3.10) (Mo et al, 2009). 
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3.4.9. Biomass synthesis reaction 
Based on the information presented in previous subsections, the synthesis reaction for 
generating 1 g of biomass in P. pastoris can be written as follows: 
(1.711) 13BDglcn[c] + (0.378) ala_L[c] + (0.051) amp[c] + (0.239) 
arg_L[c] + (0.156) asn_L[c] + (0.156) asp_L[c] + (16.75) atp[c] + 
(0.0001) clpn_PP[m] + (0.050) cmp[c] + (0.0053) cys_L[c] + (0.0013) 
damp[c] + (0.0009) dcmp[c] + (0.0009) dgmp[c] + (0.0013) dtmp[c] + 
(0.0007) epist[c] + (0.0414) ergst[c] + (0.0007) fecost[c] + (0.329) 
gln_L[c] + (0.329) glu_L[c] + (0.252) gly[c] + (0.694) glycogen[c] + 
(0.051) gmp[c] + (16.75) h2o[c] + (0.0634) his_L[c] + (0.146) ile_L[c] 
+ (0.0002) lanost[c] + (0.248) leu_L[c] + (0.224) lys_L[c] + (0.0273) 
met_L[c] + (0.0534) orn[c] + (0.0001) pa_PP[c] + (0.0086) pc_PP[c] + 
(0.0047) pe_PP[c] + (0.107) phe_L[c] + (0.130) pro_L[c] + (0.0001) 
ps_PP[c] + (0.0002) ptd1ino_PP[c] + (0.228) ser_L[c] + (0.204) 
thr_L[c] + (0.0096) tre[c] + (0.0438) triglyc_PP[c] + (0.0496) 
trp_L[c] + (0.0755) tyr_L[c] + (0.067) ump[c] + (0.198) val_L[c] + 
(0.0017) zymst[c] --> (16.75) adp[c] + (16.75) h[c] + (16.75) pi[c] 
 




The carbon per unit gram of biomass based on the above reaction was 
calculated to be about 38.2 C-mmol/gDCW. This compares well with the values of 
36.9 C-mmol/gDCW obtained from the chemostat experiment and 35.9 mmol/gDCW 
reported in an earlier analysis of P. pastoris cellular composition (Carnicer et al, 
2009). Subsequently, the above biomass synthesis reaction will be set as the cellular 
objective to be maximized under some nutrients uptake condition to predict cell 
growth of P. pastoris using the constraints-based modeling framework. 
 
3.5. Uniqueness of P. pastoris metabolism 
The final reconstructed iPP668 metabolic model of P. pastoris accounts for 668 
metabolic genes, 1,361 reactions and 1,177 metabolites segregated into 8 
compartments as summarized in (Table 3.11). The metabolic reactions include 904 
intra-compartment reactions, 308 inter-compartment reactions and 149 extracellular 
exchange reactions. These metabolic reactions are also classified into 62 subsystems 
which include pathways in central carbon metabolism, amino acid, carbohydrate, and 
lipid biosynthesis (Table 3.12). In this fully compartmentalized model, metabolites 
involved in reactions localized in different compartments are considered distinct 
metabolites, e.g. cytosolic pyruvate and mitochondrial pyruvate are two different 
metabolites. If subcellular localization is not considered, iPP668 accounts for 681 
unique metabolites. 
The uniqueness of iPP668 was evaluated by comparing the reactions in this 
model with those found in the S. cerevisiae iMM904 model (Mo et al, 2009) and the E. 
coli iAF1260 model (Feist et al, 2007). To compare reactions in yeasts with those in 
the bacteria, the compartmentalization information is ignored. From the comparison 
(Figure 3.3), the 292 reactions and 439 metabolites that are common to all three 




species were found to be mainly from the central carbon metabolism and amino acid 
biosynthetic pathways. The 415 reactions and 196 metabolites that are shared by both 
yeasts were generally classified as the lipid and carbohydrate biosynthetic pathways. 
The 79 reactions and 46 metabolites unique to P. pastoris were mainly from the 
methanol utilization pathway (Figure 3.4) and certain parts of lipid metabolism, where 
the difference arise due to the dissimilarities in relative abundances of the fatty acids. 
 
Table 3.11. Comparison of two yeast GSMMs. Data for S. cerevisiae obtained from 
iMM904 GSMM (Mo et al, 2009). 
 
Genome characteristics P. pastoris S. cerevisiae 
Genome length 9.3 Mbp 12.1 Mbp 
G+C content 41.1% 38.3% 
Coding genes 5,313 6,607 
     
Model characteristics     
No. of genes 668 904 
Gene-associated reactions 1,007 1,043 
Non gene-associated 354 534 
Intracellular reactions 1,212 1,413 
Exchange reactions 149 164 
No. of metabolites 1,177 1,228 
      







Cytosol 607 623 634 709 
Endoplasmic reticulum 28 15 28 15 
Extracellular matrix 149 12 164 14 
Golgi apparatus 15 4 17 6 
Mitochondria 235 163 241 175 
Nucleus 35 16 40 16 
Peroxisome 84 66 80 65 
Vacuole 24 3 24 3 
Inter-compartment - 452 - 574 
Total 1,177 1,361 1,228 1,577 
 





Table 3.12. Functional classification of metabolic reactions. 
 
Alanine and Aspartate Metabolism 9 Other Amino Acid Metabolism 10 
Alternate Carbon Metabolism 21 Oxidative Phosphorylation 18 
Anaplerotic reactions 10 Pantothenate and CoA Biosynthesis 16 
Arabinose Metabolism 3 Pentose Phosphate Pathway 13 
Arginine and Proline Metabolism 31 Phospholipid Biosynthesis 42 
Asparagine metabolism 2 Phospholipid Metabolism 8 
ATP maintenance 1 Porphyrin and Chlorophyll Metabolism 13 
Biomass requirement 1 Purine and Pyrimidine Biosynthesis 51 
Citric Acid Cycle 13 Pyridoxine Metabolism 8 
Complex Alcohol Metabolism 22 Pyruvate Metabolism 17 
Cysteine Metabolism 7 Quinone Biosynthesis 17 
Fatty Acid  Biosynthesis 61 Riboflavin Metabolism 11 
Fatty Acid Degradation 42 Sphingolipid Metabolism 57 
Fatty Acid Metabolism 3 Starch and Sucrose Metabolism 2 
Folate Metabolism 23 Sterol Metabolism 48 
Fructose and Mannose 
Metabolism 8 Taurine Metabolism 1 
Galactose metabolism 2 Thiamine Metabolism 12 
Glutamate metabolism 15 Threonine and Lysine Metabolism 16 
Glutamine Metabolism 3 Transport, Endoplasmic Reticular 8 
Glycerolipid Metabolism 11 Transport, Extracellular 145 
Glycine and Serine Metabolism 19 Transport, Golgi Apparatus 2 
Glycolysis/Gluconeogenesis 22 Transport, Mitochondrial 91 
Glycoprotein Metabolism 5 Transport, Nuclear 5 
Histidine Metabolism 14 Transport, Peroxisomal 20 
Methanol Metabolism 7 Transport, Vacuolar 25 
Methionine Metabolism 18 tRNA charging 35 
NAD Biosynthesis 18 Tyrosine, Tryptophan, and Phenylalanine Metabolism 34 
Nitrogen Metabolism 3 Valine, Leucine, and Isoleucine Metabolism 19 
Nucleotide Salvage Pathway 61 Xylose Metabolism 2 
Other 11 Exchange reactions 149 














Figure 3.4. Methanol utilization pathway. Reactions in black are unique to P. 
pastoris and not found in E. coli or S. cerevisiae. 
 




3.6. P. pastoris chemostat culture 
A series of chemostat culture experiments were conducted to validate the phenotypic 
predictions of the GSMM. The wild-type P. pastoris X-33 (Invitrogen, Carlsbad, CA, 
USA) was cultured in glucose minimal media with a constant volume of 800 mL 
subjected to agitation and aeration of 800 rpm and 1 vvm under dilution rates of 0.136, 
0.097, 0.065 and 0.034 hr −1. The media composition (per liter) is as follows: 50 g 
glucose, 1.5 MgSO4⋅7H2O, 3 g KH2PO4, 15 g (NH4)2SO4, 2.0 mL trace element 
solution and 1.0 mL of solution containing 2 g/L biotin in 1M NaOH. The trace 
element solution contains (per liter) 5 mL H2SO4, 4.0 g CuSO4⋅5H2O, 14.0 g 
MnSO4⋅H2O, 2.6 g Na2MoO4⋅2H2O, 4.0 g H3BO3, 4.0 g CoCl2⋅6H2O, 22.0 g 
ZnSO4⋅7H2O, 55.0 g CaCl2⋅7H2O and 37.5 g FeCl3⋅6H2O. The chemostat cultures 
were allowed to undergo at least 5 volume changes to reach steady-state before 
samples were taken to calculate cell growth, carbon dioxide liberation and oxygen 
uptake rates. 
The dry cell weight (DCW) of P. pastoris was measured after centrifuging the 
samples and washing the pellets with ultrapure water before drying at 100 °C. The 
supernatants after centrifugation were used to measure glucose concentration using 
high-pressure liquid chromatography (Gilson, Middleton, WI, USA) equipped with 
HPX 87H column (Bio-Rad, Hercules, CA, USA), ERC-7515A RI detector (ERC, 
Tokyo, Japan) and UV detector (Youngin, Seoul, Korea). Analysis of carbon, nitrogen 
and hydrogen content was performed with a CHN analyzer (Carlo Erba Instruments, 
Rodano, Italy) using lyophilized cells (Gurakan et al, 1990). The carbon dioxide 
evolution rate (CER) and oxygen uptake rate (OUR) were determined by measuring 
the fermentor’s inlet and outlet gas composition using LKM200A exhaust O2 and CO2 
analyzer (Lokas, Daejeon, Korea). Gaseous exchange rates and glucose uptake rates 




were recorded for dilution rates of 0.136, 0.097, 0.065 and 0.034 hr−1 (Table 3.13). It 
is noted that the aforementioned experiment was conducted by Dr. Ahn Jung Oh’s 
research team at the Biotechnology Process Engineering Center of the Korea 
Research Institute of Bioscience & Biotechnology. 
 
Table 3.13. Chemostat experimental data. 
 





0.136 1.39 2.23 1.85 
0.097 1.00 1.72 1.49 
0.065 0.72 1.29 1.23 
0.034 0.42 0.81 0.86 
 
 
3.7. GSMM validation 
3.7.1. Non-growth associated ATP maintenance requirement 
Using the reconstructed GSMM, the maximum theoretical biomass yield of P. 
pastoris was found to be 0.129 gDCW/mmol glucose. However, this value does not 
account for the non-growth associated ATP maintenance (NGAM) requirement which 
can relate to energy spilling reactions, turnover of macromolecules (e.g. proteins and 
nucleotides), and osmoregulation (van Bodegom, 2007). Since NGAM is required 
even when there is no cell growth, this value can be inferred by plotting the growth 
curve, as shown in Figure 3.5, and finding the intercept of the axis for glucose uptake 
rate. Consequently, it was observed that a glucose consumption of 0.108 
mmol/gDCW-hr, which corresponds to the NGAM, is needed at zero cell growth. As 
the ATP yield of iPP668 was found to be 31.5 mmol ATP/mmol glucose, a lower 
bound constraint of 3.41 mmol/gDCW-hr was imposed on the ATP maintenance 








Figure 3.5. Linear regression of glucose uptake and cell growth. The x-intercept 
indicates the non-growth associated ATP maintenance requirement which corresponds 
to a glucose uptake rate of 0.108 mmol /gDCW-hr. 
 
 
3.7.2. Validation with chemostat experimental data 
By setting the ATP maintenance requirement at 3.41 mmol ATP/gDCW-hr, 
constraints-based flux analysis is used to predict the cellular phenotype of P. pastoris 
by solving (P2) for all the glucose uptake rate measurements taken in the chemostat 
culture experiment. The in silico simulation results revealed that the constraints-based 
flux analysis of iPP668 was able to predict cell growth within 25% of the 
experimentally observed values (Figure 3.6). Furthermore, the prediction of oxygen 
uptake and carbon dioxide liberation rates were also within 20% of the experimental 
measurements (Figure 3.7 and Figure 3.8), indicating that the model is adequate. 
Under the chemostat culture experimental condition, the in silico prediction of P/O 




ratio of oxidative phosphorylation, calculated by dividing the flux of ATP synthase 
reaction by two times that of the cytochrome c oxidase reaction, was found to be 
about 2.3 mol ATP/mol O. This value is significantly higher than the P/O ratio 
observed in S. cerevisiae grown on glucose (1.5 mol ATP/mol O) in a previous report 
(Verduyn et al, 1991) probably due to the presence of the NADH:quinone 
oxidoreductase enzyme found in P. pastoris which allows for more efficient oxidative 
phosphorylation (Bridges et al, 2010). 
 
 
Figure 3.6. GSMM cell growth predictions. 
 
 









Figure 3.8. GSMM oxygen uptake predictions. 
 
 
3.7.3. Validation with omics data 
Previous omic analyses of P. pastoris can provide useful experimental data to validate 
and improve the quality of the GSMM. Among the different forms of omics data, 
metabolomics data is the most relevant as it characterizes the intracellular metabolite 




concentration profiles to provide insights into the metabolic pathway utilization 
pattern of the organism (Mashego et al, 2007). Therefore, the comparison of 
simulation results with the metabolites identified from metabolomic analysis can be 
used to validate the accuracy of the GSMM. As the constraints-based framework only 
predicts the consumption/generation rate of a metabolite instead of concentration, a 
quantitative comparison is not possible unless reaction kinetics were considered to 
establish a relationship between rates and concentrations. Therefore, a qualitative 
comparison between in silico and in vivo metabolite utilization was performed. The P. 
pastoris metabolome of 32 intracellular metabolites identified from an earlier study 
(Tredwell et al, 2011) was used as the reference list of active metabolites for 
validation. Since the experiment was performed using an initial glycerol batch phase 
followed by a methanol continuous culture, the utilization of the 32 metabolites were 
evaluated for simulations of P. pastoris cell growth under glycerol uptake only, 
methanol uptake only and glycerol/methanol (50/50) uptake conditions. The same set 
of metabolites was found to be utilized for all three conditions as summarized in 
Table 3.14. Interestingly, the GSMM did not predict the utilization of arabitol, 
glycerophosphocholine, nicotinamide, nicotinate and UDP-GlcNac which were found 
to be present in the metabolomic experiment (Tredwell et al, 2011). The metabolic 
pathways in the GSMM are further examined to understand this discrepancy. 





Table 3.14. Prediction of metabolite utilization. Metabolites involved in reactions 
with nonzero fluxes are marked with a tick while the rest are marked with a cross. 
 







































Nicotinamide and nicotinate are known to be involved in the biosynthesis of 
nicotinamide adenine dinucleotide (NAD), an essential carrier of reducing equivalents 
that mediates numerous redox reactions within the cell (Foster & Moat, 1980). 
However, an alternative NAD biosynthetic pathway via kynurenine, which does not 
involve nicotinamide and nicotinate, is present in yeast (Panozzo et al, 2002). As only 
NAD was listed as an essential biomass component, the model predicted the 
utilization of the NAD biosynthetic pathway via kynurenine without the involvement 
of nicotinamide and nicotinate as intermediates. In the case of arabitol, the five-
carbon sugar alcohol can be produced naturally by some yeasts through the activity of 
the arabitol dehydrogenase enzyme with xylulose or ribulose, derived from the 
pentose phosphate pathway, as the substrate (Saha et al, 2007; Zhu et al, 2010). 
However, the model did not predict the production of arabitol as it does not contribute 
to cell growth. Similarly, the model did not predict the synthesis of 
glycerophosphocholine and UDP-GlcNac as they were not listed as essential growth 
components in the metabolic model due to the lack of experimental quantification of 
their contributions towards cellular biomass. Nonetheless, it is noted that when the 
synthetic rates of nicotinamide, nicotinate, arabitol, glycerophosphocholine and UDP-
GlcNac were maximized, the GSMM is able to predict nonzero flux-sums, indicating 
that the model already captures the relevant biosynthetic capabilities. Therefore, the 
discrepancies between computational results and experimental observations reveal the 
knowledge gap that needs to be filled through future works to improve the GSMM 
quality and the in silico simulation methodology. 
 




3.7.4. Quality of the iPP668 model 
The quality of a genome-scale metabolic model depends on the accuracy of the 
stoichiometric matrix and the biomass composition. Many of the metabolic reactions 
in iPP668 belonging to key pathways in the central carbon metabolism were similar to 
those found in the E. coli iAF1260 and S. cerevisiae iMM904 models as illustrated in 
Figure 3.3. However, it is noted that the stoichiometric matrices of iAF1260 and 
iMM904 are not good for predicting P. pastoris cell growth due to several issues. 
An important feature of iPP668 model, which is different from the iAF1260 
and iMM904 models, is the oxidative phosphorylation pathway. The oxidative 
phosphorylation reactions in iPP668 are reconstructed based on curated stoichiometry 
obtained from literature and pathway database to reflect the efficiency of proton 
transfer in P. pastoris. The presence of the NADH dehydrogenase (complex I) 
(Bridges et al, 2010), which is known to be missing in S. cerevisiae, gives rise to a 
very significant difference in the ATP yields of iPP668 (31.5 mol ATP/mol glucose) 
and iMM904 (17 mol ATP/mol glucose) that directly affects cell growth predictions. 
Furthermore, it was observed that the growth-associated ATP requirement in iAF1260 
and iMM904 had been manipulated in silico to fit the experimental data while this 
requirement has been calculated based on reported literature values in the iPP668 
model (see section 3.4.7). Therefore, the ability to predict experimental cell growth of 
P. pastoris with less than 25 % error is a result of the high quality of reconstruction 
work that was undertaken to build the iPP668 model without the need for 
modification of reaction stoichiometry to fit the experimental data. 
 




3.8. GSMM reconstruction in systems biotechnology 
The process of reconstructing and validating a GSMM exemplifies the application of 
systems biology to integrate high-throughput genomic and metabolomic data analysis 
with computational simulations to create an in silico model that accurately captures 
the metabolic behavior of the organism (Lee et al, 2005b). Since the GSMM is 
reconstructed for biotechnological applications, this approach can be aptly called 
systems biotechnology. As the resulting GSMM was shown to adequately predict in 
vivo growth characteristics of P. pastoris, further in silico analysis will be performed 
to explore its metabolic capabilities in a later chapter, demonstrating the utility of the 
systems biotechnology framework. 
 




Chapter 4. Flux-sum analysis 
 
4.1. Reaction-centric versus metabolite-centric perspectives 
The conventional constraints-based flux analysis, discussed in Chapter 2, is 
intrinsically reaction-centric since the key descriptive variable of metabolic flux 
quantifies the extent of reaction utilization. While such an approach provides an 
intuitive representation of the metabolic flux distribution among the various pathways, 
it can be cumbersome to investigate the effects of metabolite perturbations in terms of 
“metabolite knock-out” and increasing/decreasing metabolite turnover rates. Since 
frequently used metabolites such as NADH, NADPH and ATP have been implicated 
to play an important role in metabolic pathway evolution (Schmidt et al, 2003), a 
formal characterization of metabolite turnover rates under the constraints-based flux 
analysis will be useful to identify essential metabolites and examine how alteration in 
their turnover rates can affect the overall metabolism from a metabolite-centric 
perspective. Toward this end, the metabolite-centric flux-sum analysis framework is 
developed. 
 
4.2. Flux-sum analysis 
In the constraints-based analysis of metabolic fluxes, there is no accumulation of 
intermediate metabolites due to the steady-state condition. However, the turnover rate, 
which is also equivalent to the total consumption or production rate, of the 
intermediates can be nonzero. Accordingly, this turnover rate can be quantified using 
the concept of “flux-sum” under the constraints-based framework (Kim et al, 2007a). 




The flux-sum of metabolite i , denoted as iΦ , is calculated by adding up the absolute 
values of all incoming or outgoing fluxes around the metabolites (Figure 4.1), which 
can be mathematically expressed as ∑=Φ
j
jiji vS5.0 , where ijS  and jv  have the 
same meaning as presented in section 2.4. Therefore, “flux-sum analysis” can be 
defined as the examination of the effects of metabolite turnover on cellular 
metabolism under the constraints-based flux analysis framework. To demonstrate the 
application of flux-sum analysis, the genome-scale metabolic model (GSMM) of 
Escherichia coli iAF1260 (Feist et al, 2007) was used. 
 
 
Figure 4.1. Illustration of metabolite flux-sum. Halving the absolute sum of all 
incoming and outgoing fluxes around the metabolite yields the turnover rate. In the 








4.3. Flux-sum perturbation 
4.3.1. Linearization of flux-sum 
The introduction of the flux-sum variable into the constraints-based flux analysis 
formulation enables the study of metabolite flux-sum perturbation effects on cellular 
metabolism. The turnover rate of a metabolite can be perturbed by imposing 
constraints on its flux-sum. However, if a constraint such as Ci ≤Φ  is imposed on 
the metabolite flux-sum which is also expressed as an absolute value function jij vS , 
the resultant constraints-based flux analysis formulation will become a nonlinear 
programming problem with discontinuous derivatives that is computationally difficult 
to solve (Drud, 2006). In the case of attenuating flux-sum by introducing an upper 
abound, i.e. Ci ≤Φ , a mathematical transformation has been proposed to recast the 
discontinuous nonlinear constraint into a linear form (Kim et al, 2007a). For any two 
positive numbers a and b , the following mathematical relationship is always true: 
( ) ( ) ( )babababa +≤−⇒+≤− 22 . Therefore, two positive real variables +jf  and 
−
jf  are introduced such that 
−+ −= jjjij ffvS , where +jf  and −jf  can be interpreted as 
the absolute rates of metabolite generation and consumption due to reaction j , 
respectively. Consequently, it is only necessary to specify ( ) Cff
j
jj ≤+∑ −+5.0  
instead of CvS
j







jij ≤+≤−= ∑∑∑ −+−+ 5.05.05.0 . The resulting formulation will 
still be a linear optimization problem that can be effectively solved using existing 
linear programming solvers. This method of simulating flux-sum attenuation has been 
applied to study metabolite essentiality in E. coli (Kim et al, 2007a). 




However, when the “greater than or equal to” constraint is needed to analyze 
the effects of flux-sum intensification, the hitherto mathematical development is not 
adequate to perform the task. To mathematically represent flux-sum intensification, 
the ( ) Cff
j
jj ≥+∑ −+5.0  constraint is still relevant, albeit additional constraints are 
required to ensure that only either one of +jf  and 
−
jf  can be nonzero, but not both, 
such that ( )−+ + jj ff  is still mathematically equivalent to jijvS . The simplest 
constraint to introduce is 0=× −+ jj ff , but from the computational solver’s point of 
view, this is considered a “bad” nonlinear constraint (Drud, 2006). Therefore, an 
alternative method based on the “big-M formulation” (Grossmann & Lee, 2003) is 
applied. Two sets of binary variables, { }0,1=+jI  and { }0,1=−jI , are introduced such 
that only one of them can be nonzero, i.e. 1=+ −+ jj II . These indicator variables are 
then used to constrain +jf  and 
−
jf  using the “big-M formulation”: MIf jj ⋅≤ ++  ; 
MIf jj ⋅≤ −−  where M  is some finitely large number that is at least larger that the 
largest experimentally observable metabolic flux value, e.g. 1000 mmol/gDCW-hr. 
When formulated together these integer constraints, the original nonlinear flux-sum 
can be expressed in a linear form: ( )∑ −+ +=Φ
j
jji ff5.0 . 
 
4.3.2. Flux-sum maximization 
Based on the presented flux-sum formulation, the maximum turnover rate of some 
metabolite *i  can be evaluated by solving the following mixed-integer linear 
programming (MILP) problem: 
 (P2) max ( )∑ −+ +=Φ
j
jji ff5.0*  




  s.t. ivS
j
jij metabolite0 ∀=∑  
   jvvv jjj reaction
maxmin ∀≤≤  
   * metabolite somefor * iffvS jjjji
−+ −=  
   MIf jj ⋅≤ ++  , MIf jj ⋅≤ −−  , 1=+ −+ jj II  
   { }0,1=+jI  , { }0,1=−jI  
 
The objective value corresponding to the solution of (P2), denoted by max*iΦ , 
will subsequently be used as a reference value for flux-sum intensification. 
 
4.3.3. Attenuation and intensification of flux-sum 
The flux-sum attenuation and intensification analyses were developed to characterize 
phenotypic changes associated with the perturbation of metabolite turnover rates. 
With the wild-type value as the starting point, the flux-sum of each metabolite can be 
attenuated or intensified while optimizing the cellular objective. To carry out this 
analysis on a particular metabolite *i , the following steps are performed: 




* 5.0  where jv  
is the solution of (P1). 
Step 2: Evaluate the maximum flux-sum value, max*iΦ , by solving (P2). 
Step 3: For attenuation (or intensification) analysis, the flux-sum is constrained to 
some value between 0 and B*iΦ  (or B*iΦ  and max*iΦ ) while optimizing the 
desired cellular objective. The MILP problem formulation for this step is 
shown as (P3) below. 
 




 (P3) max ∑=
j
jj vcZ  
  s.t. ivS
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jij metabolite0 ∀=∑  
   jvvv jjj reaction
maxmin ∀≤≤  
   * metabolite somefor * iffvS jjjji
−+ −=  
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   MIf jj ⋅≤ ++  , MIf jj ⋅≤ −−  , 1=+ −+ jj II  
   { }0,1=+jI  , { }0,1=−jI  
 
In (P3), “Mode 1” and “Mode 2” refer to flux-sum attenuation and flux-sum 
intensification, respectively. Therefore, depending on the mode of analysis, the 
corresponding constraint is imposed. Parameters attk  and intk  are flux-sum attenuation 
and intensification factors respectively. To generate the flux-sum attenuation and 
intensification profiles, (P3) can be solved for { }0.1,,2.0,1.0,0att −−−∈ Kk  and 
{ }0.1,,2.0,1.0,0int K∈k . 
 
4.4. Case study: Metabolite flux-sums of E. coli  
The flux-sum analysis framework detailed in the previous section was applied to 
examine the metabolism of E. coli using the iAF1260 GSMM which consists of 1668 
metabolites, i.e. 951 cytosolic intermediates, 418 perplasmic intermediates and 299 
extracellular metabolites, and 2382 reactions, including the biomass reaction, to make 
up a 1668 by 2382 stoichiometric matrix (Feist et al, 2007). Due to subcellular 




compartmentalization of metabolites in iAF1260, the same metabolite in different 
compartments are considered distinct metabolites suffixed with [c], [p] or [e] to 
indicate cytosol, periplasm or extracellular matrix localization respectively. For 
example, H2O[c], H2O[p] and H2O[e] represent three different water metabolites 
present in the three different compartments. Since flux-sum analysis deals primarily 
with the turnover rate rather than the absolute uptake or secretion rate of metabolites, 
the following analysis will mainly be based on cytosolic and periplasmic metabolites, 
which is collectively known as intermediates. 
 For all in silico constraints-based flux analysis simulations, the cellular 
objective to be maximized is biomass production. Uptake rates of glucose and oxygen 
were limited to 10 mmol/gDCW-hr and 20 mmol/gDCW-hr respectively, and the non-
growth associated maintenance energy requirement was set at 8.39 mmol/gDCW-hr to 
mimic the aerobic growth condition of E. coli in glucose minimal media. These values 
were based on previous data from cell culture experiments (Feist et al, 2007; Varma et 
al, 1993; Varma & Palsson, 1994). The simulation of basal metabolite flux-sums will 
be based on these model inputs. 
 
4.4.1. Basal metabolite flux-sums 
The distribution of basal metabolite flux-sums for E. coli was generated by solving 
the LP problem (P1) (Figure 4.2). About 70% of the metabolites in the GSMM are not 
utilized under basal condition. The maximum flux-sum of 324 mmol/gDCW-hr was 
observed for cytosolic proton which is involved in 189 active metabolic reactions. By 
defining “active-degree” as the number of active reactions involving each metabolite, 
a linear relationship between active-degree and basal flux-sum for high active-degree 
metabolites can be observed (Figure 4.3). It is noted that the term “active-degree” is 




different from the typical usage of “degree” in network topological analysis of 
interaction-based models which refers to the number of reactions, both active and 
non-active, that are connected to each metabolite (Barabasi & Oltvai, 2004). While 
the conventional topological analysis of degree distribution reveals properties inherent 
to the network structure, the concept of active-degree provides further information on 
how the nodes (i.e. metabolites) and links (i.e. reactions) are utilized to produce a 
physiological response (e.g. cell growth). 
 
 
Figure 4.2. Basal flux-sum distribution. This plot only displays the flux-sum of 406 
metabolites which are actively turned over under the wild-type condition; the rest of 
the 1262 metabolites are not utilized. Metabolites towards the left of the plots include 
frequently used metabolites such as ATP, ADP, NAD and NADH. 
 
 





Figure 4.3. Degree of active basal metabolites. For the 12 metabolites with active-




4.4.2. Flux-sum maxima 
The evaluation of flux-sum maxima from the solution of MILP problem (P2) can 
uncover the existence of blocked and cyclic metabolites. Blocked metabolites are 
analogous to the blocked reactions which can be identified by the Flux Coupling 
Finder (Burgard et al, 2004). Similar to the original concept of blocked reactions, 
blocked metabolites can either be conditionally or unconditionally blocked. 
Conditionally blocked metabolites are able to exhibit nonzero turnover rates when the 
exchange rates of all external metabolites become unconstrained while 
unconditionally blocked metabolites can only carry zero flux-sum under any 
environmental condition, as illustrated in Figure 4.4. Unconditionally blocked 
metabolites have also been referred to as “dead-ends” (Reed et al, 2003) since they 
appear on the ends of pathways either as the starting substrate or final product 
metabolite (Figure 4.4). Upon the maximization of flux-sum as formulated in (P2), the 




blocked metabolite can only yield the objective value of zero as its turnover by 
consuming and generating reactions is impossible due to the lack of either the former 
or the latter. Since all reactions connected to blocked metabolites are definitely 
blocked reactions, but no vice versa, the flux-sum maximization framework (P2) is a 
better alternative to the FCF method for identifying both blocked metabolites and 
reactions. By applying flux-sum maximization to all metabolites in the iAF1260 
metabolic model, 189 intermediates were found to be unconditionally blocked while 
442 were conditionally blocked under the aerobic glucose minimal media condition. 
 
 
Figure 4.4. Blocked and cyclic metabolites. Metabolites E and F are unconditionally 
blocked while metabolites G and H can be conditionally blocked if there is no supply 
of metabolite Gxt. Cyclic metabolites A and C are involved in internal metabolic 
cycles. 
 
On the other hand, if (P2) solves to give an objective value that is exceedingly 
high (e.g. ≥ 1000 mmol/gDCW-hr), the corresponding metabolite is inferred to be 
involved in internal cyclic metabolic pathways. These pathways have been previously 
known as “Type III” pathways which can be identified by stoichiometric network 
analysis (Schilling et al, 2000). In the iAF1260 model, 75 cyclic metabolites were 
identified. By comparing the flux-sum maxima with basal flux-sum, 55 metabolites 




were further found to be fully utilized such that the flux-sum maxima was equal to the 
basal flux-sum while 797 metabolites were partially utilized, of which 504 had zero 
basal flux-sum. 
 
4.4.3. Flux-sum attenuation analysis 
Among the 1369 intermediates in iAF1260, 394 had nonzero basal flux-sum and were 
thus amenable for flux-sum attenuation analysis. By solving (P3) under “Mode 1” 
condition, the flux-sum profile is generated for various levels of flux-sum attenuation 
quantified by the parameter attk  (Figure 4.5). The 342 metabolites that yield no 
biomass production when 1att −=k  are essential for cell growth; some of these 
metabolites involved in amino acid biosynthesis, including tetrahydrodipicolinate, 
L,L-2,6-diaminopimelate and meso-2,6-diaminopimelate, were associated with 
essential gene previously reported in a gene deletion experimental study (Gerdes et al, 
2003). These essential metabolites represent critical points of fragility in the 
metabolite network as their removal leads to cell growth inhibition. Interestingly, 
86.8% of the basal active metabolites were essential compared to 68.5% of the basal 
active reactions being lethal, implicating a higher level of reaction redundancy in the 
form of alternative metabolic pathways mediating the turnover of essential 
metabolites. This observation is also attributed to the fact that a metabolite associated 
with a lethal reaction will inevitably be essential while a reaction involving essential 
metabolite(s) may not necessarily be lethal. 
 





Figure 4.5. Flux-sum attenuation profile. The biomass level refers to the ratio of 
biomass yield with respect to the wild-type value of 0.929 gDCW/gDCW-hr predicted 
by the iAF1260 model. 
 
Although all essential metabolites results in zero cell growth when their flux-
sums are completely attenuated, the shape of their profiles can be different from one 
another and can be generally classified into three types: “A”, “B” and “C”. As similar 
profiles can be observed in flux-sum intensification analysis, the letter “E” is added to 
distinguish these metabolites as essential (Figure 4.5). The existence of 304 type 
“AE” metabolites is intuitive since biomass production is expected to vary linearly 
with the biosynthesis of essential metabolites. On the other hand, 32 metabolites 
produced type “BE” profiles due to the presence of alternate optima (Mahadevan & 
Schilling, 2003) where there exists multiple feasible flux distributions that can 
achieve the maximum cell growth such that minor reduction of the metabolite flux-
sum can be compensated. Between type “AE” and type “BE” profiles, there are also 
metabolites that exhibit a hybrid profile which can be a result of the traversing of 




optimal solution across linear edges of the solution space with different gradients as 
illustrated in Figure 4.6. 
 
 
Figure 4.6. Example of a hybrid metabolite. Given the above toy network, the 
constraints on the fluxes 1x  and 2x  can be inferred from the constraints of 1v , 2v , 3v , 
4v , and the reaction stoichiometry of Rxn1 and Rxn2. Since 1x  is the only reaction 
consuming metabolite C, it also represents the flux-sum of C. Flux-sum attenuation of 
C is performed by decreasing k , causing the objective function to move left, which in 
turn results in the hybrid profile. 
 




The flux-sum attenuation of type “CE” metabolites resulted in a more rapid 
drop in cell growth than “AE”. These six “CE” metabolites that were found to be 
essential for providing the ATP turnover requirement for non-growth associated 
maintenance (NGAM), which was set at 8.39 mmol/gDCW-hr in the simulation of 
wild-type E. coli metabolism in iAF1260. Therefore, the threshold level of flux-sum 
attenuation corresponds to the NGAM requirement. As “CE” metabolite flux-sum 
drops below the threshold level, the bacteria will begin to lose its ability to remain in 
the stationary phase since its cellular maintenance requirement is not met. 
 
4.4.4. Flux-sum intensification analysis 
Flux-sum intensification analysis can only be performed for metabolites which have 
maximum flux-sum greater than basal flux-sum. Hence, only the partially utilized 
metabolites identified from the analysis of flux-sum maxima are shortlisted. Flux-sum 
intensification analysis is not relevant for the other metabolites because: (1) blocked 
metabolites has zero flux-sum cannot be intensified; (2) flux-sum intensification of 
cyclic metabolites will only increase fluxes through Type III pathways (Schilling et al, 
2000) without affecting overall cellular metabolism; and (3) fully utilized metabolites 
have equal basal and maximum flux-sums such that there is no room for flux-sum 
intensification. 
The solution of (P3) under “Mode 2” for different values of intk  is used to 
generate the flux-sum intensification profile (Figure 4.7). The “competitive” 
metabolites in flux-sum intensification, analogous to the essential metabolites in flux-
sum attenuation, are those which cause biomass yield to become zero when their flux-
sums are fully intensified. Competitive metabolites, as illustrated in Figure 4.8, 
compete for resources required for biomass production, thus resulting in decreased 




cell growth when their flux-sums are intensified. Among the 797 partially utilized 
metabolites in the iAF1260 model, 785 are competitive and 12 are uncompetitive. 
Similar to the classification of essential metabolites in flux-sum attenuation analysis, 
competitive metabolites can be classified as type “AC” or “BC”. No metabolite was 




Figure 4.7. Flux-sum intensification profile. The biomass level refers to the ratio of 
biomass yield with respect to the wild-type value of 0.929 gDCW/gDCW-hr predicted 









Figure 4.8. Competitive and uncompetitive metabolites. This figure illustrates how 
competitive (red), uncompetitive (blue), fully utilized (yellow) and fully coupled 
(green) metabolites can be organized in the metabolic network. 




4.4.5. Flux-sum based metabolite classification 
From flux-sum analysis, several types of metabolites were identified. The metabolite 
classification performed for the iAF1260 model, summarized in Figure 4.9, can 
provide insight into the organization of cellular metabolism which can be used for 
biomedical and biotechnological applications. For example in anti-pathogen studies, 
type “AE” and type “CE” metabolites are promising drug targets since the attenuation 
of their flux-sum yields the most significant decrease in biomass yield. The flux-sum 
of most fully utilized metabolites were also found to be fully coupled with cell growth, 
similar to the concept of reaction flux coupling reported in a previous study (Burgard 
et al, 2004). Therefore, the turnover rate of these metabolites can be good indicators 
of cell viability and potential anti-pathogenic drug targets. 
 From the perspective of genome-scale metabolic model reconstruction, this 
method of metabolite classification can aid model curation. For example, when the 
model fails to predict the experimentally observed phenotypes due to incomplete 
metabolic pathways, the identification of blocked metabolites using flux-sum analysis 
can help to find the existence of potential gaps. By comparing the list of blocked 
metabolites with metabolomics data obtained from cell culture experiment, dead-end 
metabolites that are found to be present in the metabolome can then be shortlisted for 
gap-filling to complete the relevant metabolic pathways. 
 





Figure 4.9. Metabolite classification. 
 
 
4.5. Flux-sum analysis for enhancing succinate production 
In this section, the applicability of flux-sum analysis to investigate biotechnological 
issues is demonstrated in the study of succinate production in E. coli. Succinate, also 
known as amber or butanedioic acid, is a commercially valuable compound that can 
be used as a precursor to synthesize various detergents, food additives, ion chelators 
and solvents (Zeikus et al, 1999). As the industry strives towards environmentally 
sound and sustainable manufacturing technology, microbial-based production of 
succinate has gained popularity as seen in various metabolic engineering research 




(Hong & Lee, 2001; Lee et al, 2005a; Millard et al, 1996). As E. coli has been 
commonly used as the microbial host for succinate production, the developed flux-
sum analysis framework will be employed to demonstrate the metabolite-centric 
approach of identifying metabolic engineering targets. 
The mathematical formulation of flux-sum analysis is modified to identify 
potential perturbations of metabolite turnover rates that can result in increased 
succinate formation: 
 (P4) min EX_succvZ =  
  s.t. ivS
j
jij metabolite0 ∀=∑  
   kbiomassbiomass vv
max,≥  
   jvvv jjj reaction
maxmin ∀≤≤  
   * metabolite somefor * iffvS jjjji
−+ −=  
   
( ) ( )



























   MIf jj ⋅≤ ++  , MIf jj ⋅≤ −−  , 1=+ −+ jj II  
   { }0,1=+jI  , { }0,1=−jI  
 
It is noted that oxygen uptake is now set to zero since the formation of 
succinate occurs under the anaerobic condition in E. coli. Prior to solving (P4), the 
value of kbiomassv
max,  is first evaluated by solving (P3) for some value of attk  or intk . The 
value kbiomassv
max,  will then serve as a lower bound constraint for biomass production while 
the flux of succinate production, EX_succv , is minimized to calculate the minimum 




amount of succinate that must be secreted to balance the metabolic fluxes required for 
cell growth. The theoretical maxima for biomass and succinate yields were found to 
be 0.031 gDCW/mol glucose and 1.65 mol/mol glucose respectively. The biomass 
and succinate yield profiles over all levels of metabolite flux-sum 
attenuation/intensification are plotted as shown in Figure 4.10. 
 
 
Figure 4.10. Flux-sum analysis profiles. Only the profiles of potential targets 
capable of achieving at least 10% of maximum theoretical succinate yield are shown. 
 
 
4.5.1. Flux-sum attenuation target for improved succinate production 
The result of flux-sum attenuation analysis has been experimentally confirmed 
previously to show the improvement of succinate production through the reduction of 
total metabolic fluxes towards pyruvate by knocking out the genes of pyruvate-
forming enzymes (Lee et al, 2005a). As the in silico simulation also shows that 




succinate production can be decreased when pyruvate flux-sum is excessively 
attenuated (Figure 4.10A), the corresponding metabolic behavior will be further 
examined to gain a better understanding of how pyruvate flux-sum perturbation can 
alter the cellular metabolism. 
Under the anaerobic condition, the succinate dehydrogenase reaction is not 
utilized since oxygen is unavailable to regenerate the electron acceptor ubiquinone. 
Hence, instead of producing NAD through the ubiquinone-dependent NADH 
dehydrogenase reaction, NAD regeneration occurs mainly via the ethanol-producing 
acetylaldehyde dehydrogenase (ACALD) and alcohol dehydrogenase (ALCD) 
reactions, which are part of the mixed acid fermentation pathway (Figure 4.11). As 
pyruvate is the precursor for acetate, ethanol, formate and lactate synthesis, its 
formation via the pyruvate kinase (PYK) reaction competes for the metabolic fluxes 
that could potentially flow towards succinate formation. Hence, attenuating pyruvate 
flux-sum favors the redirection of metabolic fluxes at the phosphoenolpyruvate 
branch towards succinate synthesis. Since pyruvate flux-sum attenuation also causes a 
concomitant decrease in NAD regeneration by ACALD and ALCD, the metabolic flux 
is preferentially channeled towards succinate-producing malate dehydrogenase (MDH) 
and fumarate reductase (FRD), where the NAD shortage can be compensated by the 
coupling of FRD with the menaquinone-dependent NADH dehydrogenase reaction 
(Figure 4.11). Therefore, the substitution of ACALD and ALCD by MDH and FRD as 
the major NAD regenerator explains the increase in succinate production under 
pyruvate flux-sum attenuation as depicted by the right section of the succinate 
production profile (Figure 4.10A). This alteration of metabolic flux distribution to 
meet the cellular NAD regeneration requirement provides insight into how the in vivo 




deletion of ptsG and pykFA was able to give rise to more than eight-fold increase in 
succinate yield (Lee et al, 2005a). 
 
 
Figure 4.11. Mixed acid fermentation pathways. 
 
On the other hand, the left section of the profile (Figure 4.10A) can be 
explained by realizing that pyruvate flux-sum attenuation is also accompanied by 
decreased ATP regeneration due to lower acetate kinase (ACK) and pyruvate kinase 
(PYK) fluxes. Furthermore, lower pyruvate flux-sum leads to lower glucose uptake 
through the phosphotransferase system and additional ATP requirement for the 




glucokinase for converting glucose into glucose-6-phosphate to commence the 
glycolysis pathway. Hence, when ATP regeneration is attenuated below the threshold 
which affects glucose uptake, there is an immediate decrease in succinate productivity 
which results in the triangular shaped succinate production profile under pyruvate 
flux-sum attenuation. The key metabolic changes during pyruvate flux-sum 
attenuation are summarized in Figure 4.12. 
 
 
Figure 4.12. Effects of pyruvate flux-sum attenuation. In glycolysis, pyruvate 
kinase is the key producer of ATP while glyceraldehyde-3-phosphate dehydrogenase 
is the key consumer of NAD. The production of acetate, ethanol and succinate 








4.5.2. Flux-sum intensification targets for improved succinate production 
Flux-sum intensification analysis allowed us to observe the increase in succinate 
production when the flux-sum of several metabolites involved in redox reactions and 
the glyoxylate pathway were intensified (Figure 4.10B). As the succinate-forming 
FRD consumes menaquinol to produce menaquinone, flux-sum intensification of such 
metabolites is expected to directly promote succinate production. In the case of 
glyoxylate flux-sum intensification, its perturbation effect was understood by 
examining the TCA cycle with glyoxylate bypass. Under anaerobic condition, the low 
level of metabolic flux through the TCA cycle is accompanied by energy (ATP) 
regeneration mainly through substrate-level phosphorylation rather than oxidative 
phosphorylation. Thus, increasing glyoxylate flux-sum will force a redistribution of 
fluxes away from the ethanol production pathway towards the TCA cycle. 
Consequently, the role of ACALD and ALCD in the ethanol production pathway as the 
major NAD regenerator is replaced by the succinate-producing FRD in the TCA cycle, 
similar to the metabolic state observed under pyruvate flux-sum attenuation. This 
strategy has also been demonstrated in a previous experimental study whereby the 
deletion of iclR, a repressor of the glyoxylate bypass operon aceBAK (Gui et al, 1996), 
increased glyoxylate pathway utilization and enhanced succinate production yield of 
more than eight fold (Wang et al, 2006). 
 




4.5.3. Flux-sum perturbation for metabolic engineering 
The most desirable flux-sum perturbation should allow maximal succinate production 
while achieving moderate cell growth. From the growth profile (Figure 4.10), it could 
be observed that although flux-sum intensification of the metabolites in the glyoxylate 
pathway can lead to high succinate production, it is at the expense of significant 
decrease in cell growth. On the other hand, the attenuation of pyruvate flux-sum will 
be the better option since a biomass yield of more than 50 % of the maximum could 
still be achieved at the point of maximum succinate yield. Since the target identified 
by flux-sum analysis is a metabolite, the metabolic engineering strategy for modifying 
flux-sum may involve overexpression or deletion of multiple genes as demonstrated 
in previous studies (Lee et al, 2005a; Wang et al, 2006). This exemplifies the utility of 
flux-sum for identifying targets which could not have been identified via single gene 
knockout studies. Nonetheless, the practical implementation of flux-sum modification 
can be challenging as targets such as ATP, NADH and NADPH are highly connected. 
As such, many genes can be engineered to manipulate their flux-sums. A possible 
way to simplify the task is to first identify the highly active (or inactive) enzymes 
associated with the targeted metabolite via proteomics and/or transcriptomics. Then, 
these enzymes can be the prioritized metabolic engineering targets for attenuating (or 
intensifying) the flux-sum of the desired metabolite. 
Since the flux-sum analysis framework is capable of identifying promising 
metabolic engineering targets for strain improvement, this method will subsequently 
be applied to analyze the GSMM of P. pastoris to gain a better understanding of its 
metabolic behavior and devise potential strategies for enhancing its performance as a 
microbial cell factory. 
 




Chapter 5. P. pastoris GSMM analysis  
 
5.1. P. pastoris GSMM for recombinant protein production 
Pichia pastoris has been successfully used to express more than 200 recombinant 
proteins from various origins ranging from prokaryotic bacteria to eukaryotic plants 
and mammals (Cereghino & Cregg, 2000). While significant efforts have been 
devoted to develop efficient experimental protocols for heterologous protein 
expression in P. pastoris, the metabolic behavior of P. pastoris during protein 
expression remains largely unexplored. Hence, the reconstructed genome-scale 
metabolic model described in Chapter 3 will be used to examine the metabolic state of 
P. pastoris during recombinant protein production. In the following analysis, the 
target recombinant protein is assumed to be human erythropoietin (EPO) which is 
known to be an important therapeutic agent for treating anemia associated with 
chronic renal failure (Faulds & Sorkin, 1989). In the biopharmaceutical industry, there 
is a great demand for recombinant EPO making it one of the top-selling 
biopharmaceutical products where companies such as Amgen and Johnson & Johnson 
were able to generate about US$4 billion of revenue each through the sales of EPO 
drugs in the year of 2003 (Walsh, 2005). Furthermore, P. pastoris has been shown to 
be capable of producing erythropoietin in earlier experimental studies (Celik et al, 
2007; Celik et al, 2010). Thus, the analysis of EPO production using the iPP668 
GSMM to investigate the production capacity of P. pastoris from the cellular 
metabolism perspective will be relevant to the biotechnological industry. 
 




5.2. Protein synthesis in P. pastoris GSMM 
The native EPO gene found in the human genome consists of two portions: a 27-








Since the mature protein is responsible for mediating red blood cell production, 
only this portion will be expressed in the heterologous host. When P. pastoris is used 
as the expression system, the recombinant gene is typically constructed with a yeast-
specific secretion signal peptide preceding the main protein to be secreted. The 
“mating factor alpha” (MFα) secretion signal peptide is commonly used for 




The above MFα sequence been shown to be effective in enhancing secretory 
expression of human lysozyme in P. pastoris (Oka et al, 1999). Therefore, by 
prefixing the main EPO sequence with the MFα sequence, the complete protein 
sequence is obtained: 
MRFPSIFTAVLFAASSALAAPVNTTTEDETAQIPAEAVIGYLDLEGDFDVAVLPFSN
STNNGLLFINTTIASIAAKEEGVSLDKRAPPRLICDSRVLERYLLEAKEAENITTGC








Based on this complete sequence, the amino acid requirement for protein 
synthesis can be calculated as summarized in Table 5.1. To further account for the 
energy requirement involved in peptide synthesis through the charging of tRNAs with 
their respective cognate amino acid, the protein synthesis metabolic reaction is written 
as follows: 
(32) alatrna[c] + (15) argtrna[c] + (11) asntrna[c] + (11) asptrna[c] 
+ (4) cystrna[c] + (8) glutrna[c] + (18) glntrna[c] + (13) glytrna[c] 
+ (2) histrna[c] + (11) iletrna[c] + (31) leutrna[c] + (10) lystrna[c] 
+ (2) mettrna[c] + (10) phetrna[c] + (12) protrna[c] + (17) sertrna[c] 
+ (19) thrtrna[c] + (3) trptrna[c] + (5) tyrtrna[c] + (17) valtrna[c] 
--> (32) trnaala[c] + (15) trnaarg[c] + (11) trnaasn[c] + (11) 
trnaasp[c] + (4) trnacys[c] + (8) trnaglu[c] + (18) trnagln[c] + (13) 
trnagly[c] + (2) trnahis[c] + (11) trnaile[c] + (31) trnaleu[c] + (10) 
trnalys[c] + (2) trnamet[c] + (10) trnaphe[c] + (12) trnapro[c] + (17) 
trnaser[c] + (19) trnathr[c] + (3) trnatrp[c] + (5) trnatyr[c] + (17) 
trnaval[c] 
 
In the above reaction, the aminoacyl-tRNAs are used instead of the amino 
acids such that the energetic requirement involved in charging the amino acid to the 
tRNA is accounted for. 





Table 5.1. Amino acid requirements for EPO synthesis. 
 























Since EPO synthesis requires the consumption of resources in terms of ATP 
and amino acid, there will be a trade-off between EPO synthesis and cell growth. 
Given a fixed glucose uptake rate of 1 mmol/gDCW-hr, the maximum cell growth and 
EPO synthesis rates achievable are 0.13 hr−1 and 0.0041 mmol/gDCW-hr respectively; 
the trade-off between the two is illustrated in Figure 5.1. 
 





Figure 5.1. Cell growth vs. EPO synthesis trade-off. The shaded area indicates the 
feasible region for concurrent cell growth and EPO synthesis. 
 
5.3. Carbon source analysis for recombinant protein production 
In most recombinant protein production studies, the alcohol oxidase (AOX) promoter 
is used to control the expression of the recombinant gene in P. pastoris. As such, 
methanol will be used as the carbon source to induce the AOX promoter for gene 
expression. However, P. pastoris grows very slowly when fed with only methanol as 
the sole carbon source (Cregg, 2007). Therefore, it is relevant to explore other 
substrates that can be supplied to provide the additional carbon source to improve cell 
growth and recombinant protein productivity. Through constraints-based flux analysis 
of the iPP668 model, cell growth and EPO synthesis simulations under various carbon 
source uptake conditions were performed. The examined carbon sources, including 
glucose, glycerol, lactate, mannitol, sorbitol, succinate and trehalose, were those that 
had been experimentally shown to be utilized by P. pastoris for cell growth (Inan & 
Meagher, 2001; Kurtzman et al, 2010). For a fair comparison of simulation results, 
the uptake rates of various carbons sources were set at 1 C-mmol/gDCW-hr. 




Accordingly, the uptake rates are 0.167 mmol/gDCW-hr for glucose, 0.333 
mmol/gDCW-hr for glycerol and 0.25 mmol/gDCW-hr for succinate. 
 The constraints-based flux analysis shows that the highest growth rate can be 
achieved when P. pastoris is fed with glycerol, while the lowest growth rate is 
observed under succinate uptake (Figure 5.2). The significantly higher oxygen 
requirement for growth on methanol is consistent with experimental data (Sola et al, 
2007). In general, carbon sources with hydrogen-to-carbon ratio greater than 2 (i.e. 
glycerol, mannitol, methanol and sorbitol) yield respiratory quotients (carbon dioxide-
to-oxygen ratio) greater than 1 while the respiratory quotients for less reduced carbon 
sources are less than 1. Therefore, even though the use of more reduced carbon 
sources such as glycerol, mannitol and sorbitol can theoretically improve P. pastoris 
yield, the practical realization of this growth enhancement may be limited by 
inadequate oxygen supply. 
To further illustrate the effects of carbon source on flux distribution and 
metabolite turnover rates, a heat-map was generated for comparison (Figure 5.3). The 
flux and flux-sum distributions during methanol uptake were the most distinct as there 
is a significantly higher utilization of pentose phosphate pathway, which is needed for 
the regeneration of xylulose-5-phosphate that is required to assimilate methanol into 
the central carbon metabolism (refer to Figure 3.4 for details). Consequently, high 
flux-sums of metabolic precursors, erythrose-4-phosphate, fructose-6-phoshate, 
glyceraldehyde-3-phosphate and ribose-5-phosphate, are attributed to xylulose-5-
phosphate regeneration rather than biosynthesis of biomass components. ATP flux-
sum was also found to be the highest during methanol uptake which indicates that the 
higher respiratory quotient was associated with the generation of ATP through 
oxidative phosphorylation. 







Figure 5.2. Overall growth characteristics. The plot above shows the theoretical 
growth yield and gaseous exchange rates when P. pastoris consumes each carbon 
source at a rate of 1 C-mmol/gDCW-hr. 
 





Figure 5.3. Flux and flux-sum distributions. 




5.4. P. pastoris for whole-cell biotransformation 
When P. pastoris cell growth is simulated during uptake of more reduced carbon 
sources such as glycerol, mannitol, methanol and sorbitol, a high turnover rate was 
observed for the metabolite NADH. This cosubstrate has been known to be a crucial 
cofactor for biocatalytic ketone reduction, which is an important biochemical reaction 
for producing value-added chiral alcohols (Goldberg et al, 2007a; Goldberg et al, 
2007b; Kroutil et al, 2004). In this aspect, the high NADH turnover observed in the 
carbon source analysis can be harnessed for the whole-cell biotransformation 
application of P. pastoris to produce chiral alcohols. Towards this end, flux-sum 
attenuation analysis is used to identify potential bottlenecks, represented by type 
“AE” metabolites (see subsection 4.4.3), in the metabolic network that can be targeted 
for genetic engineering to achieve higher NADH regeneration rates. 
The MILP (P3) is solved for the maximization of NADH regeneration rates 
under “Mode 1” to generate the flux-sum profiles for different carbon source uptake 
(Figure 5.4).  The maximum NADH regeneration rates for 1 C-mmol/gDCW-hr 
uptake of glycerol, methanol, mannitol and sorbitol are 2.33, 2.00, 2.13 and 2.13 
mmol/gDCW-hr, respectively. From the flux-sum attenuation profiles, potential 
metabolite targets which can limit NADH regeneration were identified. For glycerol, 
mannitol and sorbitol uptakes, ATP was found to be the metabolite which strongly 
reduces NADH regeneration when its flux-sum is attenuated. In the case of methanol 
uptake, more metabolite targets including formaldehyde, hydrogen peroxide and 
oxygen were found to be potential bottlenecks. As these metabolites are found in the 
methanol utilization pathway (Figure 3.4), the activity of the associated enzymes, 
including alcohol oxidase, formaldehyde dehydrogenase and dihydroxyacetone 
synthase, can have a strong influence on NADH regeneration. Incidentally, this 




finding has been verified by a recent experimental study of P. pastoris whole-cell 
biotransformation for bioreduction of acetoin to form 2,3-butanediol which reported 
that the overexpression of formaldehyde dehydrogenase greatly enhances NADH 
regeneration and the overall biocatalytic activity (Schroer et al, 2010). As 
demonstrated in this case study, the presented flux-sum analysis framework can be 
used to explore potential biotechnological applications of P. pastoris and develop 
relevant strain improvement strategies. 
 
 
Figure 5.4. Flux-sum attenuation profiles for different carbon sources. 
 
The GSMM of P. pastoris can be a very useful tool when the assumptions 
made by constraints-based modeling method are valid. It is noted that in the event 
where there is a significant alteration in the yeast’s biomass composition or the 
organism is no longer allocating its metabolic resources optimally for cell growth, the 




current modeling approach will require some modifications to improve its fidelity. In 
this regard, existing techniques for identifying alternative cellular objective can be 
used (Gianchandani et al, 2008; Schuetz et al, 2007). Furthermore, the modeling 
framework can be extended to account for transcriptional regulation of metabolic 
pathways by incorporating Boolean rules into the flux constraints as demonstrated in 
previous studies (Covert & Palsson, 2002; Covert et al, 2008). 
 




Chapter 6. Codon optimization methodology 
 
6.1. Designing synthetic genes for heterologous protein expression 
In the previous chapter, the metabolic capabilities of P. pastoris in producing 
recombinant protein have been explored. The analysis of cellular metabolism can 
effectively tackle the problem of metabolic resource allocation for protein synthesis. 
However, the heterologous protein productivity of the microbial host also depends on 
the efficiency of other biological processes including DNA-to-mRNA transcription 
and mRNA-to-protein translation. In the case of P. pastoris, the transcription process 
can be enhanced by using the promoters of high-expression genes such as alcohol 
oxidase, glyceraldehyde 3-phosphate dehydrogenase and glutathione-dependent 
formaldehyde dehydrogenase to express the heterologous gene (Cereghino & Cregg, 
2000). On the other hand, improvement of the translation process requires more 
sophisticated methods which analyze the various factors affecting the polymerization 
of amino acids mediated by the binding of tRNAs to the appropriate codons within the 
ribosome (Figure 6.1). Codon usage pattern, being implicated as an important factor, 
has been commonly used as the main criteria for designing synthetic genes for 
heterologous protein expression (Gustafsson et al, 2004). However, the existing tools 
for optimizing the codon usage pattern of synthetic genes are inefficient and do not 
consider certain unique aspects of codon usage. Therefore, this part of the thesis aims 
to develop novel computational procedures for designing synthetic genes with optimal 
codon usage patterns. 
 





Figure 6.1. mRNA-to-protein translation. 
 
 
6.2. Codon usage diversity 
The degeneracy of the genetic code, reflected by the use of sixty-four codons to 
encode twenty amino acids and translation termination signal, gives rise to the 
situation whereby all amino acids, except methionine and tryptophan, can be encoded 
by two to six synonymous codons (Table 6.1). Notably, the synonymous codons are 
not equally utilized to encode the amino acids, thus resulting in the phenomenon of 
codon usage bias which was first reported in a study that examines the occurrence 
frequencies of 61 amino acid codons (i.e. termination codons are excluded) in 90 
genes from various organisms (Grantham et al, 1980). The emergence of codon usage 
bias in organisms has been largely attributed to natural selection, mutation, and 
genetic drift (Hershberg & Petrov, 2008). More importantly, codon usage bias has 
been shown to be correlated to gene expression level (Duret & Mouchiroud, 1999; 
Gouy & Gautier, 1982). As a result, codon usage bias has been proposed as an 
important design parameter for optimizing recombinant protein production in 
heterologous expression hosts (Gustafsson et al, 2004). 





Table 6.1. Synonymous codon(s) of amino acids. 
 
Amino acid Abbreviation Synonymous codon(s) 
Methionine M AUG 
Tryptophan W UGG 
Cysteine C UGC, UGU 
Aspartate D GAC, GAU 
Glutamate E GAA, GAG 
Phenylalanine F UUC, UUU 
Histidine H CAC, CAU 
Lysine K AAA, AAG 
Asparagine N AAC, AAU 
Glutamine Q CAA, CAG 
Tyrosine Y UAC, UAU 
Isoleucine I AUA, AUC, AUU 
Alanine A GCA, GCC, GCG, GCU 
Glycine G GGA, GGC, GGG, GGU 
Proline P CCA, CCC, CCG, CCU 
Threonine T ACA, ACC, ACG, ACU 
Valine V GUA, GUC, GUG, GUU 
Leucine L CUA, CUC, CUG, CUU, UUA, UUG 
Arginine R AGA, AGG, CGA, CGC, CGG, CGU 
Serine S AGC, AGU, UCA, UCG, UCC, UCU 
(Stop) * UAA,UAG,UGA 
 
 
As wild-type foreign genes are usually expressed poorly in the heterologous 
host, the application of synthetic biology to synthesize artificial gene constructs with 
customized sequence design has become a popular strategy for overexpression of 
heterologous proteins (Welch et al, 2009). To achieve high levels of heterologous 
gene expression, the synthetic gene should adopt the codon usage bias of the 
expression host. In the case of expressing recombinant human erythropoietin (EPO), 
the EPO gene sequence should be redesigned to use the synonymous codons in the 
same proportions as the native genes such that EPO can be efficiently expressed in P. 
pastoris. Based on the amino acid composition of EPO (Table 5.1) and number of 




synonymous codons for each amino acid (Table 6.1), the total number of possible 
DNA sequences encoding EPO can be more than 1028. Among these sequences, there 
will be some that exhibit codon usage patterns which closely mimic the natural codon 
usage of P. pastoris (Figure 6.2). To effectively identify the few promising candidates 
from the huge number of feasible sequences, a computational optimization algorithm 
can be implemented. 
 
 
Figure 6.2. Codon usage distribution of P. pastoris. The unbiased codon usage 
(blue lines) together with the codon usage of high-expression (green bars) and low-
expression (red circles) genes in P. pastoris are shown. 
 





6.3. Individual codon usage optimization (ICO) 
Optimization is an essential step for finding the line of best fit in many mathematical 
modeling studies (Giordano et al, 2009). The computational optimization or 
mathematical programming algorithm searches for the best solution in the feasible 
space by manipulating some dependent variables. In the same manner, an 
optimization approach can be applied to identify the best synthetic gene design by 
improving the individual codon usage (ICU). To formulate the optimization problem, 




Using the example of recombinant EPO with MFα signal peptide as the target protein 
to be produced, the primary structure can be described as a sequence of amino acids 
mathematically denoted as: 




,,,,,,,,,,, === τ*RDGFISPFRM K  
where 1,iτ  refers to the amino acid occupying the thi  position of the amino acid 
sequence A,1S  with the subscript 1 indicating that this is the target protein and n  
refers to the sequence length, which is 252 for the recombinant EPO. Each 1,iτ  
belongs to the set of unique amino acids which also includes the translation 
termination signal. Therefore, the following relationship can be established: 
{ } { } ijji ∀==Α∈ = *YWDCA ,,,,,,2111, Kατ  




In this study, the nucleotide sequence will be defined in terms of nucleotide 
triplets instead of individual nucleotides as the primary concern is the manipulation of 
codons. Therefore, the coding sequence of the EPO gene will be mathematically 
written as: 




,,,,,,,,,,, === λUGAAGAGACGGGUUUAUUUCACCUUUUAGAAUG K  
where 1,iλ  refers to the codon variable in the thi  position of the target coding 
sequence 1C,S . Every variable 1,iλ  belongs to the set of 64 unique codons such that: 
{ } { } ikki ∀==Κ∈ = UUUUUGAAGAACAAA ,,,,,6411, Kκλ  
By defining a function f  to map any codon to its corresponding amino acid 
sequence, the translation of mRNA to protein can be written as ( )1,1, ii f λτ =  for 
individual codons, or ( )C,1A,1 SfS =  for the entire coding sequence. In ICU 
optimization (ICO), every 1,iλ  is a variable while 1,iτ  is a predefined constant. 
Therefore, the constraint ( ) 1,1, iif τλ =  delineates the feasible solution space of the ICO 
problem. It is noted that in this writing, the subscript will be consistently used to 
indicate the position in a sequence while the superscript will indicate the index for 
elements in a unique set. 
 
6.3.2. Definition of fitness 
After defining the variables (codons) and constraint (target protein sequence), the 
final component of the optimization problem formulation is the objective function. In 
ICO, the aim is to search for a candidate coding sequence which exhibits an ICU 
pattern that is most similar to the host’s. Therefore, a fitness measure can be used to 




quantify the similarity between the ICU distributions of the host and the designed 
coding sequence, subsequently known as the “subject”. 
The ICU distribution can be mathematically written as a vector of individual 
codon frequencies. The frequency of a codon can be calculated by dividing the 
number of codon occurrences in a coding sequence by the total number of 
corresponding amino acid occurrences in the target protein sequence. The counts of 
codons and amino acids are mathematically formulated as follows: 
Host’s count for amino acid j : 









j ατθ  
Host’s count for codon k : 









k κλθ  
Subject’s count for amino acid j : 









j ατθ  
Subject’s count for codon k : 









k κλθ  
where { }•1  is an indicator function such that { } ⎩⎨
⎧=
otherwise0





It is noted that the host’s codon and amino acid counts are calculated for a group of 
selected native genes (details of gene selection will be discussed later) while the 
subject’s counts are calculated for the target protein sequence only. Hence, the host’s 




counts are summed over the total number of amino acids/codons in all the genes 
denoted by n′ . Accordingly, the host’s codon frequency can be calculated as: 



















And the subject’s codon frequency can be calculated as: 




















The ICU distributions can also be written as vectors of 64 ICU frequencies, i.e. 
0p  and 1p . Thus, the ICU fitness of the subject with respect to the host can be 














6.3.3. ICO mathematical formulation 
By combining the mathematical expressions presented thus far, the ICO problem can 
be formulated as follows: 
 (P4) max ICUΨ=Z  
  s.t. { }n
ii
S
11,1,A == τ  
   { }n
ii
S
11,1,C == λ  
   ( ) { }nif ii ,,11,1, K∈∀=τλ  
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6.3.4. Solving the ICO problem 
Due to the discrete codon variables and nonlinear fitness expression of ICUΨ , the 
above is a mixed-integer nonlinear programming (MINLP) problem. Nonetheless, the 
problem can be linearized using a similar strategy shown earlier in Chapter 4. By 
decomposing the nonlinear expression kk pp 10 −  into a series of linear and integer 
constraints which consist of binary and positive real variables, the MINLP problem 
(P4) can be recast into a MILP problem (Chung & Lee, 2009). Although such an 
optimization problem can be solved using MILP solvers, there is a faster method for 
generating a subject with optimal ICU using the following steps: 
1. Calculate the host’s ICU distribution, kp0 .  
2. Calculate the subject’s amino acid counts, jA,1θ . 




3. Calculate the optimal codon counts for the subject: 








kk καθθ  
4. For each iτ  in the subject’s sequence, randomly assign a codon kκ  if 0C >kθ , 
and decrement k optC,θ  by one. 
5. Repeat step 4 for all amino acids of the target protein from 1,1τ  to 1,nτ . 
 
 
Figure 6.3. ICO schematic. 
 




Unlike existing implementations of ICO in gene design softwares, such as 
Codon optimizer (Fuglsang, 2003), GeneDesigner (Villalobos et al, 2006), and 
OPTIMIZER (Puigbo et al, 2007), which utilizes computationally intensive genetic 
algorithms and sampling methods, the above computational procedure is able to 
effectively generate an ICU optimal sequence using a non-iterative approach (Figure 
6.3). 
 
6.4. Codon context optimization (CCO) 
Apart from individual codon usage (ICU) bias, the nonrandom utilization of adjacent 
codon pairs in various organisms has also been reported in earlier studies (Tats et al, 
2008; Yarus & Folley, 1985). This phenomenon is also termed “codon context” as it 
implicates some “rule” for organizing neighboring codons as a result of potential 
tRNA-tRNA steric interaction within the ribosomes (Gutman & Hatfield, 1989; Smith 
& Yarus, 1989). Codon context (CC) was shown to correlate with translation 
elongation rate such that the usage of rare codon pairs decreased protein translation 
rates (Coleman et al, 2008). Furthermore, a patented technology, known as 
“Translation Engineering”, demonstrated that better enhancement in translational 
efficiency could be achieved by optimizing codon pair usage in addition to ICO 
(Hatfield & Roth, 2007). Regardless of these findings, the CC optimization (CCO) 
was yet to be implemented in any of the available synthetic gene design tools. 
Therefore, the development of a computational approach for CCO is presented and 
the performance of CCO and ICO will be compared. 
 




6.4.1. CCO mathematical formulation 
The mathematical formulation of CCO is similar to that of ICO. In the context of CC, 
the target coding sequence is expressed as a sequence of codon pair variables: 
{ } { } 1
11,CC,1
,,,,,, −=== niiS γAGAUGAGACAGAGGGGACUUUCCUAGAUUUAUGAGA K  
where 1,iγ  refers to the codon pair variable in the thi  position of the target coding 
sequence CC,1S . It is noted that the sequence CC,1S  is different from sequence C,1S  as 
the former set consists of 1−n  codon pairs while the latter is made up of n  codons. 
By defining a concatenation function ( )bag ,  to append the string  b  to right of string 
a , the relationship between 1,iλ  and 1,iγ  can be stated as ( )( )1,11,1, , += iii g λλγ . Every 
codon pair variable encodes for the corresponding amino acid pair, i.e. 
( ) ( )( )1,11,1, , += iii gf ττγ , and they each belong to the unique sets of amino acid and 
codon pairs defined as follows: 
( )( ) { } { } { }1,,1,,,,,,,, 42011,11, −∈∀==Β∈ =+ nig jjii KK βττ *YW*DAADCAACAA  
{ } { } { }1,,1,,, 390411, −∈∀==Ρ∈ = nikki KK ργ UUUUUUAAAAACAAAAAA  
 
Therefore, the counts and frequencies for amino acid and codon pairs can be 
expressed as follows: 
 
Subject’s count for amino acid pair j : 









j βττθ  
Subject’s count for codon pair k : 









k ργθ  




Subject’s frequency of codon pair k : 




















Host’s count for amino acid pair j : 









j βττθ  
Host’s count for codon pair k : 









k ργθ  
Host’s frequency of codon pair k : 




















By denoting the CC distributions of the host and the subject as 0q  and 1q , the 














Consequently, the mathematical formulation of the CCO problem is as follows: 
 (P5) max CCΨ=Z  
  s.t. { }n
ii
S
11,A,1 == τ  
   { } 1
11,CC,1
−
== niiS γ  
   ( ) ( )( ) { }1,,1, 1,11,1, −∈∀= + nigf iii Kττγ  
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 The above MINLP problem can also be recast into an MILP problem with the 
same strategy shown in the previous subsection (6.3.3) such that existing MILP 
solvers can be using to find an optimal sequence design. However, due to the large 
discrete search space, the MILP solvers which use either branch-and-bound or branch-
and-cut methods will still require a huge amount of computational resources to find 
the optimum solution (Atamtürk & Savelsbergh, 2005). Thus, a more efficient method 
for solving (P5) is needed. 
 




6.4.2. Solving the CCO problem 
The non-iterative computational procedure described for ICO may not be applicable 
to solve the CCO problem due to the complexity which arises from the dependency of 
adjacent codon pairs. For example, given a codon pair “AUG-AGA” in a 5’-3’ 
direction, the following codon pair can only start with “AGA”. Therefore, the 
application of the non-iterative procedure to directly identify the codon pairs and 
randomly assign them to the respective amino acid pairs can lead to conflicting codon 
pair assignments in certain parts of the sequence. Since the characteristic of 
independency, which was exploited to develop a simple solution procedure for ICO, is 
absent in the CCO problem, a more sophisticated computational approach is required. 
The CCO problem can be conceptualized in a similar way as the well-known 
traveling salesman problem whereby the traversing from one codon to the next 
adjacent codon is analogous to the salesman traveling from one city to the next 
(Applegate, 2006). Since there will be a “cost” incurred by taking a particular “codon 
path”, the CCO problem aims to minimize of the total cost for traveling a codon path 
that is able to code the desired protein sequence. However, the CCO problem is more 
complex than the traveling salesman problem due to the nonlinear cost function 
evaluation based on the frequency of codon pair occurrence. Hence, heuristic 
optimization methods will be the most appropriate for finding a reasonably good 
solution for such a large-scale combinatorial problem within an acceptable period of 
computation time. Incidentally, the use of genetic algorithm (Goldberg, 1989) 
provides an intuitive framework whereby codon path candidates are “evolved” 
towards optimal CC through procedures which mimic the natural evolutionary 
processes of selection, crossover or recombination and mutation (Figure 6.4). 
 





Figure 6.4. CCO schematic. 
 
The steps involved in the implementation of genetic algorithm for CCO is as follows: 
1. Randomly initialize a population of coding sequences for target protein. 
2. Evaluate the CC fitness of each sequence in the population. 
3. Rank the sequences by CC fitness and check termination criterion. 




4. If termination criterion is not satisfied, select the “fittest” sequences (top 50% 
of the population) as the parents for creation of offsprings via recombination 
and mutation. 
5. Combine the parents and offsprings to form a new population. 
6. Repeat steps 2 to 5 until termination criterion is satisfied. 
 
In step 3, the termination criterion depends on the degree of improvement in 
best CC fitness values for consecutive generations of the genetic algorithm. If the 
improvement in CC fitness across many generations is not significant, the algorithm is 
said to have converged. In this study, the CCO algorithm is set to terminate when 
there is less than 0.5% increase in CC fitness across 100 generations, i.e. 
( ) ( ) 005.0CC100CC <ΨΨ + rr  where r  refers to the thr  generation of the genetic algorithm. 
When the termination criterion is not satisfied, the subsequent step 4 will perform an 
elitist selection such that the fittest 50 % of the population are always selected for the 
reproduction of offsprings through recombination and mutation. During 
recombination, a pair of parents is chosen at random and a crossover is carried out at a 
randomly selected position in the parents’ sequences to create 2 new individuals as 
offsprings. The offsprings subsequently undergo a random point mutation before they 
are combined with the parents to form the new generation.  
Unlike traditional implementations of genetic algorithm where individuals in 
the population are represented as 0-1 bit strings, the presented CCO algorithm 
represents each individual as a sequential list of character triplets indicating the 
respective codons. Therefore, the codons can be manipulated directly with reference 
to a hash table which defines the synonymous codons for each amino acid. As a result, 
the protein encoded by the coding sequences is always the same for every generation 




of the genetic algorithm since crossovers only occur at the boundary of the codon 
triplets and mutation is always performed with reference to the hash table of 
synonymous codons for each amino acid. 
 
6.5. Multi-objective codon optimization (MOCO) 
In ICO, the optimum coding sequence is not unique since the synonymous codons are 
free to occupy any of their respective amino acids’ positions while preserving the 
optimal ICU distribution. Therefore, the ICU optimized coding sequence can be 
further optimized with respect to CC. However, the resultant ICU-CC optimized 
sequence will not exhibit a CC fitness as high as the CC-optimized sequence due to 
the trade-off between ICU and CC fitness. To understand the extent of this trade-off, 
the multi-objective codon optimization (MOCO) is used to simultaneously optimize 
ICU and CC fitness. 
 
6.5.1. MOCO mathematical formulation 
Based on the formulations for ICO and CCO, the MOCO problem can be 
mathematically formulated as follows: 
 (P6) max ( )CCICU ,ΨΨ=Z  
  s.t. { }n
ii
S
11,A,1 == τ  
   { }n
ii
S
11,C,1 == λ  
   { } 1
11,CC,1
−
== niiS γ  
   ( ) { }nif ii ,,11,1, K∈∀=τλ  
   ( ) ( )( ) { }1,,1, 1,11,1, −∈∀= + nigf iii Kττγ  
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6.5.2. Solving the MOCO problem 
Due to the complexity attributed to CCO, solution to (P6) will also require a heuristic 
optimization method. In this case, the nondominated sorting genetic algorithm-II 
(NSGA-II) is used to solve the multi-objective optimization problem (Deb et al, 2002). 
The procedure for NSGA-II is similar to that presented for CCO except for additional 
steps required for identifying and ranking the nondominated solution sets to 
eventually obtain the pareto optimum front. The NSGA-II procedure for solving the 
MOCO problem is as follows: 
1. Randomly initialize a population of coding sequences for the target protein. 
2. Evaluate ICU and CC fitness of each sequence in the population. 
3. Group the sequences into nondominated sets and rank the sets. 
4. Check termination criterion. 
5. If termination criterion is not satisfied, select the “fittest” sequences (top 50% 
of the population) as the parents for creation of offsprings via recombination 
and mutation. 
6. Combine the parents and offsprings to form a new population. 
7. Repeat steps 2 to 6 until termination criterion is satisfied. 
 
The identification and ranking of nondominated sets in step 3 is performed via 
pair-wise comparison of the sequences’ ICU and CC fitness. For a given pair of 




sequences with fitness values expressed as ( )1CC1ICU ,ΨΨ  and ( )2CC2ICU ,ΨΨ , the 
domination status can be evaluated as follows: 
• If ( )2ICU1ICU Ψ>Ψ  and ( )2CC1CC Ψ≥Ψ , sequence 1 dominates sequence 2. 
• If ( )2ICU1ICU Ψ≥Ψ  and ( )2CC1CC Ψ>Ψ , sequence 1 dominates sequence 2. 
• If ( )2ICU1ICU Ψ<Ψ  and ( )2CC1CC Ψ≤Ψ , sequence 2 dominates sequence 1. 
• If ( )2ICU1ICU Ψ≤Ψ  and ( )2CC1CC Ψ<Ψ , sequence 2 dominates sequence 1. 
 
Whenever a particular sequence is found to be dominated by another sequence, 
the domination rank of the former sequence is lowered. As such, the grouping and 




In the original nondominated sorting algorithm (Deb et al, 2002), the set of 
individuals that is dominated by every individual is stored in memory. Therefore, for 
a total population of n , the total storage requirement is ( )2nO . However, for the 
abovementioned algorithm, only ( )nO  storage is required for storing the domination 
value of each individual. In terms of computational complexity, both the original and 
Initialize domination ranks of all individuals to zero; 
For every individual i where i loops from 1 to (n-1), 
 For every individual j where j loops from i to n, 
  If individual i dominates individual j, 
   Increment domination value of j; 
  Else if individual j dominates individual I, 
   Increment domination value of i; 
Sort individuals based on domination ranks; 




modified algorithms require at most ( )2mnO  computations for m  objective values 
since all the n  individuals have to be compared pair-wise for every objective to be 
optimized. Therefore, the nondominated sorting algorithm presented in this thesis is 
superior on the whole, especially with regards to the computational storage 
requirement which can become an important issue when dealing with very long 
coding sequences. 
The output of multi-objective optimization is a set of solutions also known as 
the pareto optimal front. Since the aim of MOCO is to examine the relative effects of 
ICU and CCO, it is not necessary to analyze all the sequences in the pareto optimal 
front. Instead, only the solution closes to the ideal point is required for further analysis 
as it represents a sequence with “balanced” ICU and CC fitness optimality. A 
graphical representation of the relative locations of the ICO, CCO and MOCO 
solution sequences on a fitness plot is shown in Figure 6.5. 
 
 
Figure 6.5. Codon optimization solutions. Optimized sequences generated by ICO, 
CCO and MOCO are labeled as ICOx , CCOx  and MOCOx  respectively. 
 




Chapter 7. Comparison of ICO and CCO 
 
7.1. Codon optimization in P. pastoris 
The novel computational procedures presented in Chapter 6 are capable of designing 
synthetic genes exhibiting optimal individual codon usage (ICU) and/or codon context 
(CC) fitness with respect to the expression host. In general, ICU and/or CC 
optimization of synthetic genes can be performed as illustrated in Figure 7.1. 
Although earlier studies have shown that these codon optimization approaches can 
lead to better heterologous protein expression (Gustafsson et al, 2004; Hatfield & 
Roth, 2007), none has compared the relative effectiveness of ICU and CC 
optimization towards enhancing recombinant protein production. Therefore, the 
performance of the three different codon optimization approaches, i.e. ICO, CCO and 
MOCO will be evaluated using the P. pastoris expression host. 
 





Figure 7.1. Codon optimization workflow. 
 
 
7.2. ICU and CC preference of P. pastoris 
Codon optimization is usually employed in cellular engineering studies to increase the 
expression of a particular gene. Therefore, the codon usage pattern of genes that are 
efficiently translated will be “preferred”. To elucidate the underlying mechanisms of 




efficient translation of mRNA to protein mediated by the ribosomes, the integrated 
analysis of transcriptome, translatome and proteome data will be the most relevant as 
demonstrated in earlier studies (Zouridis & Hatzimanikatis, 2007; Zouridis & 
Hatzimanikatis, 2008). However, such heterogeneous large-scale experimental data 
are not readily available for the extraction of codon usage preference information in P. 
pastoris. Alternatively, it is assumed that the organism have evolved to conserve 
resources by only producing high amounts of transcripts for genes that can also be 
efficiently translated. In this way, the available transcriptome data from microarray 
experiments can be used to identify the highly expressed and supposed efficiently 
translated genes. Thus, the codon pattern of the host’s native high-expression genes 
will be a suitable reference point for codon optimization. 
The step for selecting high-expression genes as the basis for codon 
optimization is only relevant if the following two conditions are true: (1) ICU and CC 
distributions of high-expression genes are significantly biased and nonrandom; and (2) 
there is a significant difference in ICU and CC distribution between highly expressed 
genes and all the genes in the host organism’s genome. If the first condition is false, 
there is no codon (pair) bias and codons can be assigned randomly based on a uniform 
distribution. On the other hand, if the second condition is false, the computation of 
ICU and CC distributions based on all the genes in the genome will be sufficient to 
characterize the ICU and CC preference of the organism without the need for 
selecting high-expression genes. Thus, the differences in codon patterns between 
highly expressed genes, subsequently known as type H genes, and all genes in the 
genome, subsequently known as type A genes, will be analyzed using statistical 
methods. 
 




7.2.1. Pearson’s chi-squared test for biasness in ICU and CC distributions 
In this study, the type H genes of P. pastoris are defined as the top 5% of highly 
expressed genes observed in a previously reported microarray experiment (Vijay 
Kumar & Rangarajan, 2011). To ascertain the significance of biasness in the ICU and 
CC distributions of these genes, the Pearson’s chi-squared test is performed for every 
amino acid. The Pearson’s chi-squared test is first used to test the significance of ICU 
and CC bias of type H genes. By stating the null hypothesis as “the ICU (CC) of type 
H genes follows the unbiased uniform distribution”, the chi-square statistic for amino 



















where HijE  and 
H
ijO  are the expected and observed numbers of synonymous codon 
(pair) i  encoding amino acid (pair) j , respectively. The constant Hjn  refers to the 
number of unique synonymous codon (pair) encoding the amino acid j ; for example, 
the Hjn  values for asparagine, glycine and leucine are 2, 4, and 6 respectively. The 
superscript “H” indicates that only the type H genes are used to evaluate the 
respective values. Given the null hypothesis of unbiased codon (pair) usage, HijE  can 






E =  where HjN  refers to the total number of amino acid (pair) 
j  found in the type H genes. The p-value is then evaluated by comparing the 
calculated 2,1 jΧ  value against the 2χ  distribution with ( )1−Hjn  degrees of freedom 










Using a p-value cut-off of 0.05, the amino acid (pair) with biased ICU (CC) 




distribution that is significantly different from the unbiased uniform distribution can 
be identified. This test of ICU and CC biasness will be referred to as “χ 2 Test 1”. To 
ensure the statistical adequacy of this chi-squared test, any amino acid (pair) with low 
expected occurrence (i.e. 5<HijE ) will be omitted from this analysis as recommended 
in an earlier report (Cochran, 1954). Furthermore, chi-squared test of singular amino 
acids (methionine and tryptophan) and amino acid pairs (pairs only composed of 
methionine and/or tryptophan) are also not relevant since they are not encoded by 
more than one synonymous codon (pair) since the chi-squared statistic will always be 
equal to 1. 
The abovementioned Pearson’s chi-squared formulation is slightly modified to 
determine whether the ICU (CC) is significantly different between type H and type A 
genes. By stating the null hypothesis as “ICU (CC) of type H genes is the same as that 
of type A genes”, the expected number of codon (pair) i  in high-expression genes is 









E =~  
where AijO  refers the observed number of codon (pair) i  encoding amino acid (pair) j  
and AjN  refers to the total number of amino acid (pair) j . The superscript “A” 
indicates that type A genes are used for evaluating the respective values. The chi-





















Similarly, the calculated 2,2 jΧ  value is compared against the 2χ  distribution with 
( )1−Hjn  degrees of freedom with a p-value cut-off of 0.05 to identify any amino acid 




(pair) with significantly biased ICU (CC) distribution. This test for evaluating the 
difference in ICU and CC distributions between high-expression genes and all genes 
in the genome will be referred to as “χ 2 Test 2”. 
 
Table 7.1. Pearson’s chi-squared tests. Singular amino acids (pairs) and those with 
expected counts less than 5 are not amenable to the chi-squared test and classified as 
“unevaluated”. Abbreviations: DH, codon (pair) distribution of high-expression genes; 
DA, codon (pair) distribution of all genes; U, uniform distribution. 
 
 χ 2 Test 1 χ 2 Test 2 
Null hypothesis (H0) DH = U DH = DA 
Alternative hypothesis (H1) DH ≠ U DH ≠ DA 
Organism EC PP SC EC PP SC 
No. of biased amino acids 
(p-value < 0.05) 18 18 18 17 19 19 
No. of unbiased amino acids 
(p-value ≥ 0.05) 1 1 1 2 0 0 
No. of singular amino acids 2 2 2 2 2 2 
No. of unevaluated amino acids 
(expect count < 5) 0 0 0 0 0 0 
Total no. of amino acids 21 21 21 21 21 21 
No. of biased amino acid pairs 
(p-value < 0.05) 314 354 372 99 259 282 
No. of unbiased amino acid pairs 
(p-value ≥ 0.05) 26 38 19 23 36 9 
No. of singular amino acid pairs 4 4 4 4 4 4 
No. of unevaluated amino acid pairs 
(expect count < 5) 76 24 25 294 121 125 
Total no. of amino acid pairs 420 420 420 420 420 420 
 
 
Results from χ 2 Test 1 and 2 revealed that the ICU and CC distributions of at 
least 80% of the amino acids (pairs) amenable to the chi-square test are significantly 




based for the type H genes when compared to the unbiased distributions. Notably, in 
the high-expression genes, aspartate was found to be the only single amino acid 
exhibiting an ICU distribution that is not significantly different from the unbiased 
distribution for P. pastoris. Similarly, in the comparison of type H and type A genes, 
there is also a significance difference in the distributions for at least 80% of the amino 
acids (pairs). Consequently, the chi-squared test analysis clearly indicates that the 
selection of highly expressed genes for the computation of ICU and CC distribution is 
crucial for capturing the ICU and CC preference of P. pastoris accurately. Hence, the 
sequences of the top 5% of highly expressed genes as reported in the P. pastoris 
microarray experiment (Vijay Kumar & Rangarajan, 2011) will be used to calculate 
the host’s preferred ICU and CC distributions. 
 
7.2.2. Principal component analysis of ICU and CC distributions 
A principal component analysis was also performed for types H and A genes to 
visualize their differences with respect to ICU and CC distributions among different 
expression hosts including E. coli, P. pastoris and S. cerevisiae. The high-expression 
genes constitute the top 5% of all genes observed in previous microarray experiments 
for E. coli (Faith et al, 2007), P. pastoris (Vijay Kumar & Rangarajan, 2011) and S. 
cerevisiae (Knijnenburg et al, 2009). From the PCA results (Figure 7.2), there is a 
clear difference in both ICU and CC distributions between high-expression genes and 
all the genes from the entire genome for all the microbes. The close proximity of the 
overall ICU and CC distributions of P. pastoris and S. cerevisiae in the PCA plots 
could be attributed to their close phylogenetic relationship as they are both classified 
as ascomycete yeasts under the order of Saccharomycetales (Suh et al, 2006). 
However, as P. pastoris and S. cerevisiae evolved in their respective natural habitats, 




the different environment conditions could have exerted different selection pressures 




Figure 7.2. PCA of ICU and CC distributions. The first two components (PC1 and 
PC2) are plotted for the PCA of ICU and CC distributions of high-expression (H), 
low-expression (L) and all genes (A) from the genomes of E. coli (EC), P. pastoris 
(PP) and S. cerevisiae (SC). The unbiased distribution (U) is also included. 
 
  
7.2.3. Alternative methods of evaluating ICU and CC preference 
Through the investigation of ICU and CC biasness, the selection of high-expression 
genes was found to be relevant for the evaluation of ICU and CC preference for codon 
optimization. Interestingly, many of the previous codon optimization studies have 
used the codon frequency information provided by the Codon Usage Database 8 
(Nakamura et al, 2000) to evaluate the organism’s codon usage preference. This 
database compiles the codon usage frequencies for each organism based on the coding 
sequences of all genes found in the genome. Since prior filtering of highly expressed 
genes was not performed, the resultant codon usage data may reflect some degree of 
preference for “rare” codons, thus leading to low gene expression (Kane, 1995). 
Moreover, some of the earlier codon optimization studies utilized a method which 
                                                 
8 http://www.kazusa.or.jp/codon/ 




only assigns the most frequently used codon for each amino acid, also known as the 
“one amino acid – one codon” or “CAI = 1.0” approach. The codon adaptation index 
(CAI), which has been commonly used to describe codon usage bias, quantifies the 
extent of synonymous codon usage with respect to the most frequently used codon. 
Due to the positive correlation between CAI and gene expressivity (Sharp & Li, 1987), 
the maximization of CAI to achieve CAI = 1.0 has been used to generate optimal 
sequence designs whereby only the most frequently used codon codes for each amino 
acid. This gene design strategy can become problematic because overexpression of 
this gene may lead to rapid depletion of the specific cognate tRNAs resulting in tRNA 
pool imbalance, which in turn cause an increase in translational errors (Kurland & 
Gallant, 1996). Therefore, the proposed approach of optimizing codons according to 
the complete ICU and CC distributions of highly expressed genes will be suitable to 
alleviate the problem of tRNA pool imbalance when the cell is induced to overexpress 
the target gene. As such, the concept of CAI is not considered in this study as this 
single value does not capture as much detail as the ICU and CC distributions. 
 
7.3. Cross-validation of codon optimization approaches 
The efficacy of ICO, CCO and MOCO are evaluated using an in silico leave-one-out 
cross-validation procedure, whereby a gene is randomly selected from the entire set of 
high-expression genes as the test sequence for optimization while the rest of the genes 
will be used as the training set to calculate the reference ICU and CC distribution 
(Figure 7.3). 
 





Figure 7.3. Codon optimization cross-validation workflow. 
 
 
The rationale for this cross-validation is that the best computational procedure 
will be able to generate a sequence design that is most similar to the corresponding 
wild-type sequence. Therefore, by comparing the computationally optimized sequence 
with the respective wild-type sequence, the performance of the computational 




procedures can be evaluated. As the degree of similarity to the wild-type genes 
indicates the potential in vivo gene expressivity of the optimized sequences, the 
quality of each optimized sequence was measured in terms of the percentage of 
matching codons denoted by Mp . As a benchmark, the random codon assignment 
(RCA) computational procedure, which randomly assigns a synonymous codon for 
each amino acid in the protein sequence, was used to generate sequences for each 
gene to establish the Mp  baselines for comparison. The average Mp  of all the 
optimized sequences generated by each computational approach is shown in Figure 
7.3. The fitness values and the degree of similarity, in terms of Mp , among the 
different types of sequences for P. pastoris genes are also summarized in Table 7.2. 
The results clearly show that all the optimization methods developed in Chapter 6 
performed better than the RCA control. Furthermore, the performance of CCO was 
found to be the best among all the optimization methods, suggesting that CC is a more 
influential design criterion than ICU for designing synthetic genes for high expression. 
 
Table 7.2. Summary of fitness values and similarity measures. The Mp  values are 






Average Mp  (%) 
ICO CCO MOCO RCA WT 
ICO -0.0426 -0.1252 100 48.4 43.9 35.5 43.3 
CCO -0.1390 -0.1012 48.4 100 56.9 35.5 51.9 
MOCO -0.0436 -0.1105 43.9 56.9 100 35.0 46.4 
RCA -0.1692 -0.1398 35.5 35.5 35.0 100 35.5 
WT -0.1322 -0.1232 43.3 51.9 46.4 35.5 100 
 




In addition, the optimized sequences of each high-expression gene in P. 
pastoris generated by the different methods were compared pair-wise in a tournament 
style. For example, when the CC optimized sequence has a higher Mp  than ICU 
optimized sequence for a particular gene, the CCO method is awarded one “win” for 
the tournament. As such, the total number of wins for each of the optimization 
methods can be tabulated into a tournament matrix as shown in Table 7.3. The 
sequence tournament analysis further corroborates the hypothesis that CCO is 
superior to ICO with 96 % of CC optimized sequences having higher Mp  than the 
ICU optimized counterparts. The simultaneous optimization of CC and ICU fitness 
using MOCO was also found to have better performance that ICO for 83 % of the 
sequences, albeit losing out to CCO in 86 % of the instances (Table 7.3). This 
suggests that the improvement of CC fitness at the expense of ICU fitness can 
potentially enhance the in vivo gene expressivity of the synthetic gene. 
 
Table 7.3. Tournament matrix. The number in each cell indicates the number of 
wins (losses) per 100 tournaments by the optimization approach indicated in the 
leftmost (topmost) column (row). 
 
  ICO CCO MOCO RCA 
ICO − 4 15 93 
CCO 96 − 86 100 
MOCO 83 12 − 99 
RCA 6 0 1 − 
 
 
7.4. In vivo protein expression of optimized sequences 
To further evaluate the relative effectiveness of ICU and CC fitness optimization, the 
ICO, CCO and MOCO algorithms were applied to optimize the lipase B gene from 




Candida antarctica for expression in P. pastoris. As the lipase B of C. antarctica has 
been widely used as a biocatalyst for stereoselective synthesis of organic compounds 
(Anderson et al, 1998), the ability to produce high titers of the enzyme through 
heterologous expression will be an important contribution. Therefore, a variant of the 
lipase B gene (CALB14) created through random mutagenesis for high expression in 
Hansenula polymorpha was used as the wild-type gene for codon optimization (Kim 
et al, 2007b). ICO, CCO and MOCO were employed to generate three synthetic 
coding sequences. The expression vectors for the wild-type, ICO, CCO and MOCO 
lipase genes were constructed together with the translation elongation factor 1-α 
promoter from P. pastoris as described in a previous study (Ahn et al, 2007). Each of 
the engineered P. pastoris strains was inoculated in a 250 mL baffled flask using 10 
mL of YPD medium containing 20 g/L of glucose, 10 g/L of yeast extract and 20 g/L 
of Bacto-peptone incubated at 30 °C with an agitation rate of 150 rpm for 14 hours. 
This seed culture is subsequently separated into two aliquots of 5 mL, each transferred 
into a 500 mL baffled flask containing 100 mL of YPD medium incubated for another 
48 hours at 30 °C with an agitation rate of 200 rpm before measuring the cell density 
and lipase activity. The cell density of the yeast was estimated by measuring the 
optical density at 600 nm (OD600) with the Uvicon-930 spectrophotometer and 
multiplying the reading with a predetermined conversion factor of 0.27 gDCW/L per 
unit OD600. Lipase activity was determined through pH-stat analysis with the 718 
STAT Titrino instrument using olive oil emulsion as the substrate solution which is 
composed of 5 mL olive oil in 495 mL salt solution containing 1.17 g/L of NaCl, 0.2 
g/L of CaCl2⋅7H2O and 5 g/L of gum arabic. One unit of lipase activity (U) was 
defined as the amount of enzyme required for releasing 1 μmol of fatty acid per 
minute. The aforementioned experiment was conducted by Dr. Ahn Jung Oh’s 




research team at the Biotechnology Process Engineering Center of the Korea 
Research Institute of Bioscience & Biotechnology. 
At the end of cell culture, the cell density was found to be approximately 
OD600 = 12 ± 0.5 for all experimental runs. The amounts of secreted lipase for the 
different lipase genes, measured in units of U/gDCW, clearly showed a positive 
relationship between CC fitness and protein production level (Figure 7.4). This 
finding corroborates the in silico validation results, implicating CC fitness as the more 
important design parameter than ICU fitness for enhancing heterologous gene 
expressivity. Although the presented heterologous lipase expression experiment may 
not be extensive enough to indicate a general positive correlation between CC fitness 
and gene expressivity, it shows promising preliminary results which can motivate 
future works in large-scale multi-gene codon optimization to analyze the effects of 
various gene design parameters. 
 
 
Figure 7.4. Heterologous expressivity of lipase genes. The error bars indicate the 
standard deviations of the two experimental replicates for each type of lipase gene. 
 
 




7.5. Efficacy of CCO 
Although codon usage patterns has been shown to have a strong influence on the 
accuracy and speed of mRNA translation (Sorensen et al, 1989; Stoletzki & Eyre-
Walker, 2007), the CCO method, which was shown to be the best optimization 
approach, can only deliver the desired results if translation elongation is indeed the 
rate-limiting step of the entire protein expression process. Incidentally, there was 
evidence suggesting that translation initiation rather than elongation is the rate 
limiting step (Bulmer, 1991). Nonetheless, optimizing the CC fitness of the coding 
sequences may indirectly help to increase translation initiation by freeing up more 
ribosomes through enhanced translation elongation rates. The increased pool of free 
ribosomes can improve translation initiation by mass action effect. 
Another issue that may cause translation initiation to be rate limiting is the 
mRNA structure of the initiation site. At the primary structure level, the Shine-
Dalgarno sequence or Kozak sequence is usually added to the 5’ end of the 
prokaryotic or eukaryotic coding sequence, respectively, as they have been shown to 
be necessary for the recognition of the AUG start codon to initiate translation (Kozak, 
1999). At the secondary structure level, it was found that hairpin, stem-loop and 
pseudoknot mRNA structures can repress protein translation (Kozak, 2005). Although 
this suggests that the computationally intensive mRNA secondary structure evaluation 
may be required for designing synthetic genes, it was also reported that the helicase 
activity of ribosome is able to disrupt the secondary structures for mRNA translation 
(Takyar et al, 2005). Therefore, it is recommended that the mRNA secondary 
structural analysis may be used as a supplementary filtering step on the CC-optimized 
sequences to discard the potentially problematic candidates such that no significant 
computational cost is added to the main CCO procedure. 




7.6. Potential applications of CCO 
Codon optimization can enable the enhancement of gene expression for 
overproduction value-added biochemicals which are by-products in cellular 
metabolism. Gene overexpression in metabolic engineering has conventionally been 
achieved by increasing the number of gene copies number through the use of fast-
replicating plasmids. However, the metabolic burden associated with plasmid 
maintenance can be detrimental to cell growth and biochemical production (Corchero 
& Villaverde, 1998; Diaz Ricci & Hernandez, 2000; Ow et al, 2009). Thus, codon 
optimization provides an alternative approach for enhancing pathway utilization via 
the insertion of a low copy number high-expression synthetic gene which can be 
integrated into the chromosome without the need for high plasmid maintenance 
requirement. Thus, CCO can be employed for strain improvement of cellular systems 
where gene overexpression is required to modify metabolic pathway utilization and/or 
improve protein production in biotechnological applications. 
Outside the arena of biotechnological research, codon optimization can also be 
used in the biomedical field where modulation of protein expression in a particular 
host is required to alter physiological response. For example, in the development of 
vaccines against viruses, the targeted virus can be genetically manipulated to obtain a 
“live attenuated” strain that can serve as a vaccine for the desired host. Such a vaccine, 
when administered to the host, will elicit a mild immune response that is sufficient for 
the development of immunologic memory and specific immunity against the virus 
without severe disruption to the overall physiology. Some conventional methods of 
developing live attenuated vaccines include laboratory adaptation of virus in non-
human hosts and random/site-directed mutagenesis (Wareing & Tannock, 2001). 
Since the wild-type virus is able to hijack the gene expression machinery of the host 




for replication, the “de-optimization” of viral codon usage with respect to the human 
host is a promising strategy for developing live attenuated vaccines as demonstrated 
in a recent study (Coleman et al, 2008). Therefore, the CCO procedure can be 
modified to design synthetic virus composed of more rare codons which can be used 
as a live attenuated vaccine. Specifically, the objective function can be either inverted 
to minimize the CC fitness or altered to use a reference CC distribution which is 
different from the host’s such that the resulting sequence design will be the attenuated 
form of the virus. 
 
7.7. Rare codons and protein folding 
The use of frequently occurring codons has been known to improve translation 
elongation rates, thus enhancing protein expression (Gingold & Pilpel, 2011). 
Nonetheless, in some cases, the usage of rare codons may be favorable to allow 
proper folding of the protein by retarding the rate of peptide elongation (Komar, 
2009). A previous experimental study in E. coli has also shown that the manipulation 
of host’s codon bias to improve translation efficiency led to poor protein solubility 
and reduced cell growth, implicating the importance of retarding translation 
elongation for proper protein folding by rare codons (Rosano & Ceccarelli, 2009). 
Therefore, in hosts like E. coli, the efficacy of the CCO method may be limited unless 
molecular chaperones such as GroEL/GroES, DnaJ and DnaK are co-expressed to 
facilitate proper co-translational folding of the target protein (Hardesty et al, 1999). 
Alternatively, the CCO framework can be further expanded to incorporate the need 
for rare codons at specific regions of the coding sequence to allow the enhanced 
production of biologically active and soluble recombinant proteins. 
 




Chapter 8. Conclusion 
 
8.1. Summary of contributions 
This thesis demonstrates the application of a systems biotechnology framework 
towards understanding the cellular physiology of P. pastoris and improving its utility 
as a microbial cell factory for industrial production of valuable biochemicals. The 
reconstruction of the GSMM, iPP668, was the first to be reported for the 
methylotrophic yeast (Chung et al, 2010). In the validation of iPP668 with 
experimental data, constraints-based flux analysis of the GSMM was able to predict in 
vivo growth characteristics of P. pastoris. With a small prediction error of about 25%, 
the steady-state modeling of iPP668 can be a helpful tool for studying the cellular 
metabolism of P. pastoris. To further enhance the capability of constraints-based flux 
analysis, the flux-sum analysis methodology was developed to provide a means of 
examining the effects of changes in steady-state metabolite turnover rates on cellular 
metabolism. When P. pastoris cell growth was simulated for various carbon source 
uptake conditions, the analysis of metabolite flux-sums led to the discovery of the 
organism’s potential as a biocatalyst for whole-cell bioreduction of ketones to 
produce valuable chiral alcohols. In the case study of converting acetoin to 2,3-
butanediol, the essential metabolite targets identified by flux-sum analysis were in 
agreement with previous experimental findings (Schroer et al, 2010). 
While constraints-based flux analysis of iPP668 allows the systematic analysis 
of cellular metabolism for redirection of fluxes to satisfy the demand for metabolic 
resources, it is unable to tackle the issue of low heterologous protein expression which 
is largely attributed to poorly adapted coding sequence of the target gene. Towards 




this end, computational methods were developed to design synthetic genes for optimal 
expression of any target protein. Surprisingly, the comparison of the two design 
criteria, individual codon usage (ICU) and codon context (CC), suggested that CC 
was a more influential factor in determining protein expression even though ICU has 
been commonly considered in the development of many existing gene design tools. 
Experimental results of heterologous expression of codon optimized sequences in P. 
pastoris also indicated that CC optimized genes have superior in vivo protein 
expression capabilities. Hence, the incorporation of CCO in the development of future 
gene design software is expected to be a valuable contribution to the biotechnology 
industry and also the increasingly popular field of synthetic biology. 
 
8.2. Future perspectives 
Recent advancement in synthetic biology has enabled the use of artificial 
biomolecules to produce non-natural cellular behavior in the engineered organism 
(Benner & Sismour, 2005; Leonard et al, 2008). The synergy between synthetic 
biology and metabolic engineering allows greater flexibility in the development of 
strain improvement strategies (Nielsen & Keasling, 2011). Consequently, a shift in 
metabolic engineering paradigm from “manipulation of natural genes” to 
“incorporation of artificial genetic constructs” can be observed. This phenomenon is 
exemplified by the seminal work of Keasling’s research group which demonstrated 
the use of a synthetic protein scaffold to optimize the spatial organization of enzymes 
in a metabolic pathway for enhancing the production of mevalonate, a precursor for 
the synthesis of malaria drug artemisinic acid (Dueber et al, 2009). 
As the collection of biological parts increases and the technique for 
assembling them continues to advance, more sophisticated artificial genetic circuits 




can be constructed (Peccoud et al, 2008; Shetty et al, 2008). Such advancements in 
synthetic biology can help to overcome the challenge of experimentally modulating 
the metabolite turnover rate (as discussed in Chapter 4), which can be difficult to 
achieve using conventional metabolic engineering strategies. Therefore, the 
combination of synthetic biology and the flux-sum analysis methodology can become 
a valuable tool for future strain improvement studies. Moreover, the synthetic 
biological concept of artificial metabolic pathway construction can be adapted to 
expand the flux-sum analysis framework to investigate the possibility of incorporating 
synthetic pathways to control metabolite turnover rates (Martin et al, 2009). 
One key contribution of this thesis is the development of computational tools 
for designing synthetic genes. In synthetic biology, the commonly used multi-
component genetic circuits are composed of standard biological parts which are able 
to perform certain functions in the native expression host (Canton et al, 2008). 
However, when such a genetic circuit is introduced into different expression hosts, the 
desired biological response may not be always observed due to limited heterologous 
expression of the foreign genes (Gustafsson et al, 2004). Therefore, the coding 
sequences will require some modifications to improve its expression. Towards this 
end, the cost-effective gene optimization method based on codon pair usage or codon 
context (CC) developed in Chapter 6 will be a beneficial tool to synthetic biologists. 
The CC optimization approach can also be incorporated into existing oligonucleotide 
design software, such as DNAWorks (Hoover & Lubkowski, 2002), Gene2Oligo 
(Rouillard et al, 2004), GeneDesign (Richardson et al, 2010; Richardson et al, 2006) 
and TmPrime (Bode et al, 2009), to provide an integrated platform that facilitates the 
de novo synthesis and expression optimization of artificial genes. 




The presented systems biotechnology framework which employs in silico 
tools to enable the use of high-throughput omics data for the analysis and 
optimization of P. pastoris from a systems perspective is expected to become a 
valuable tool for researchers who are engaged in the burgeoning field of synthetic 
biology. While conventional synthetic biology is mostly concerned with the creation 
of artificial biological devices to perform novel cellular functions, the incorporation of 
systems biotechnology can potentially lead to innovative applications of synthetic 
biology to expand the biotechnological capabilities of industrial microbes. 
Accordingly, this new paradigm of introducing synthetic biological components to 
systematically modify the physiology of a micro-organism for improved 
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